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A BSTRAC T
The first chapter consists of a review of the background 
literature and provides a general introduction to the current study.
Various aspects of the chemistry of altemariol and the bio­
synthetic interrelationships of this key Altemaria altemata product 
to other phenolic metabolites of this fungus, are described in the 
remaining two chapters. The principal findings are summarised below:
(i) A conspicuous feature of altemariol and its derivatives is the
intense fluorescence associated with the tricyclic ring system.
This fluorescence is lost on opening the 6-lactone ring which
under acidic conditions undergoes spontaneous recyclisation.
The rate of lactone formation was found to be highly dependent 
upon the extent of methylation of the phenolic hydroxyl sub­
stituents, particularly that present at C(4’).
(ii) The chemistry of various bromo derivatives of altemariol and 
its methyl ethers have been investigated.
(iii) Thin layer chromatographic and autoradiographic procedures were 
developed for the analysis of biosynthetically-derived 1 Re­
labelled metabolites of A. altemata. Eight strains of the 
species, while differing quantitatively in their ability to 
produce altemariol and its congeners, were shown to be 
qualitatively similar. A corresponding observation of the 
metabolism of the botrallin-producing mould Botrytis allii 
indicated a close taxonomic relationship between these two genera.
iii
(iv) Two low altemariol-yielding strains of A. altemata were 
observed to metabolise altemariol when added to growing 
cultures. This effect was more pronounced on feeding the 
acidic form obtained on hydrolysis of the 6-lactone to the 
dehydroaltenusin-producing strain (T139) and led to considerably 
enhanced yields of this metabolite, in addition to a significant 
increase in mycelial growth.
(v) An autoradiographic examination of the products formed on 
incubating the lactonic acid form of (01 kCH3) -altemariol mono­
methyl ether with mycelia of A. altemata T139, clearly 
demonstrated the incorporation of this precursor into dehydro­
altenus in.
(vi) In contrast to the stimulation of mycelial growth by altemariol 
and its monomethyl ether, the di and trimethyl ethers were shown 
to exert a marked inhibitory effect.
iv
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CHAPTER 1 
INTRODUCTION
21.1 Primary and secondary metabolites
The characteristic chemical constituents of living organisms are 
biosynthesised via a wide range of enzyme-catalysed reactions of 
varying specificity. All organisms possess certain common metabolic 
pathways, involving key compounds such as sugars, amino acids, the 
common fatty acids, mononucleotides and macromolecules derived from 
these substances (i.e. polysaccharides, proteins, lipids, RNA, DNA, 
etc.). This is generally considered as primary metabolism, and these 
compounds, which are essential for the survival and well-being of the 
organism, are regarded as primary metabolites (Table 1.1).
On the other hand, secondary metabolism involves relatively 
■ specific biosynthetic processes leading to the formation of complex 
products many of which are not further metabolised in the parent 
organism. These are of restricted taxonomic distribution and play no 
obvious role in the survival of the organisms which produce them 
(Table 1.1).
Secondary metabolites are formed from primary metabolites, 
through a series of exclusively dedicated pathways each requiring a 
unique sequence of reactions. Structural analysis of secondary 
metabolites frequently indicates their modes of derivation from 
primary precursors, and tracer experiments with labelled precursors 
can be used to test the validity of such hypothetical pathways.
Clearly, secondary metabolites include a broad range of natural 
products, probably with diverse functions, and consequently they are 
difficult to classify in unambiguous terms. It is perhaps most 
convenient to generally regard them simply as compounds which are
3not obvious primary metabolites of the type listed in Table 1.1. 
Major classes of secondary metabolites include terpenes, alkaloids 
and various phenolic compounds (Table 1.2), for example, many fungal 
phenols which are formed from acetyl-CoA and malonyl-CoA by a 
modification of the pathway leading to the synthesis of fatty 
acids, known collectively as polyketides.
TABLE 1.1 Characteristics of primary and secondary metabolites1
Primary metabolites:
(a) Products of general metabolism
(b) Broad distribution in plants animals and microorganisms, 
e.g. amino acids, acetyl-CoA, monosaccharides, mevalonic 
acid, nucleotides.
Secondary metabolites:
(a) Products of specialised pathways
(b) Biosynthesised from primary metabolites
(c) Restricted distribution found mostly in plants and 
microorganisms (often characteristic of individual 
genera, species or strains),e.g. alkaloids, terpenes, 
phenols, oligosaccharides, antibiotics
Most biochemists are traditionally concerned with primary 
metabolism, whereas more studies of the structure and biosynthesis 
of secondary metabolites is chiefly the concern of the natural 
product chemist.
The systematic study of the so-called secondary metabolites of
42fungi began with the research of Raistrick and co-workers (1931), 
but these investigations were chiefly concerned with their detection 
and structure determination rather than their mode of biosynthesis.
The structure and biosynthesis of many polyketide secondary 
metabolites and the isotopic labelling patterns resulting from 
specific incorporation of radioactive precursors, have been frequently 
reviewed (Bentley,1962;  ^ Bu’Lock, 1965;  ^ Turner, 1971; 5 
Mann, 1978, 6 )
TABLE 1.2 Biosynthetic classification of secondary metabolites1 
Primary precursors Secondary metabolites
Amino-acids
Mevalonic acid 
Me OH
(H0CH2CH2-n-C/- CH2C00H)
Monos accharides
Acetyl-CoA and 
propionyl-CoA
C2 units (ex formate 
and methione)
Alkaloids
Peptide derivatives (e.g. penicillin) 
Non-nitrogenous products
(e.g. cinnamic acid derivatives)
Terpenes, sterols, carotenoids and 
general polyisoprenoids
Glycosides, oligosaccharides (e.g. 
streptomycin) and modified sugars 
(e.g. kojic acid)
Polyketides: fatty acid derivatives, 
polyacetylenes, macrolides and 
numerous phenols
-OMe, -SMe, ^ NMe,— CMe^CCHzOH 
groups, etc.
1.2 Secondary metabolites derived from acetate 
A very large number of natural products are derived from acetyl
5coenzyme A, as listed under polyketides in Table 1.2. This group 
excludes products derived from acetate via mevalonic acid, for 
example, the polyisoprenoids.
The term ’polyketide’ was coined in 1907 by Collie 7 and later 
applied more explicitly by Birch to describe aromatic natural 
products which are formed in nature from acetic acid via poly-3- 
keto intermediates. However, the polyketides include many other 
structural classes of natural products, predominant among which are 
the fatty acids.
1.2.1 Biosynthesis of fatty acids
The inherently simplest mode of biosynthesis would be formation 
by multiple ’head-to-tail’ condensation of acetate.
The discovery of the acetylation coenzyme (coenzyme A) by
9 10 Lipmann, Nachmansohn and Berman, and the identification of the
A ’active C2 unit’ as the acetyl thioester of coenzyme A (Acetyl CoA)11
were prerequisites to the isolation and characterisation of the
12various intermediates involved in fatty acid oxidation. The
intermediates are linked to coenzyme A. These observations led to 
the postulation that fatty acid synthesis is the exact reversal of 
3-oxidation. Experimental evidence supporting fatty acid synthesis
via ’a modified scheme for reversal of 3-oxidation sequence’ came
13 14from two independent observations by Langdon and Wakil et al.
Another pathway for the de novo synthesis of fatty acids from 
acetyl-CoA via the intermediate, malonyl-CoA, has been described, 
as being independent of the enzymes of the 3-oxidation sequence;
615—16
malonyl-CoA was demonstrated to be a key intermediate in
this system. The primary product of this synthesis was found to be 
palmitic acid. Wakil 16 isolated the first intermediate in the 
synthesis of long-chain fatty acids from acetyl CoA and thus split 
the reaction sequence into two parts. The first reaction was the 
formation of malonyl-CoA by the carboxylation of acetyl-CoA in the 
presence of ATP, Mn , and a biotin-containing enzyme, acetyl-CoA 
carboxylase according to the following equation:
acetyl-CoA carboxylase
MeGOSCoA + CO2 + ATP --- ---- ----- — ----
bound-biotin + Mn
-♦ H00CCH2C0-SCoA + ADP + Pi
The second reaction in the synthesis of fatty acids was the 
conversion of malonyl-CoA to palmitate 17 in the presence of 
acetyl-CoA, NADPH, and the second enzyme preparation according to 
the following:
MeCOSCoA + 7HOOCCH2CO-SCoA + 14NADPH + I4H+
— ► Me(CH2)nCOOH + 7C02 + 14NADP+ + 8CoA-SH + 6H20
The overall mechanism of biosynthesis is shown in Fig. 1.1 
In all probability the cyclic series of reactions take place within 
the confines of a multi-enzyme complex, with individual thiol ester 
intermediates passing from one enzyme thiol group to the next. In 
step 1, the acetyl group of acetyl-SCoA is transferred to the acyl, 
carrier protein, and in step 2 it is subsequently transferred to the 
active site thiol of the condensing enzyme. Malonyl-SCoA is similarly 
transfoimed into malonyl-SACP (step 3), condensation follows (step 4), 
etc.
7Step 1: MeCOSCoA + HSP MeCOSP + CoASH
Step 2: MeCO-SP + HSECond MeCO-SECond + P-SH
Step 3: 02CCII2C0-SCoA + HSP ^  02CCH2C0-SP + CoASH
?H+
Step 4: MeCO —  SECond — »MeCOCH2COSP + C02 + HSECond
(ch2-co-sp
- V '
0 - C = 0
Step 5: MeC0*CH2C0SP MeCHOH*CH2COSP MeCH = CH-CO-SP
v=^MeCH2CH2-C0-SP 
(recycled to step 2)
(L
FIG. 1.1 Synthesis of fatty acids by the ’malonate pathway’ 
(P is the acyl-carrier protein)
1.2.2 Biosynthesis of phenolic polyketides
1 8—19Collie (1893, 1907) prepared dehydroacetic acid and showed in
the laboratory that it could be converted into an aromatic compound.
These reactions suggested to Collie that aromatic compounds might arise
in plants from polyacetic acids, formed by head-to-tail condensation
of acetate units ( Fig. 1.2). The structural analysis of a number
20-21
of natural phenolic compounds supported this view (Robinson, ) 
despite the absence of experimental support. In the course of extra-
8 22polating the known biochemical data on fatty acid biosynthesis, Birch * 
independently arrived at the same conclusion as Collie and provided the 
first experimental evidence for the biochemical ’acetate' route to 
aromatic compounds.
MeC02H
Acetic acid
-► MeCOCH 2 COCH 2 COCH 2 COOH
Tetra-acetic acid
-H20
OH
CQMe
0
Dehydro acetic acid
HC1
(-C02)
0
Me ‘0 Me
2,6-Dime thyl-4-Pyrone
(+H20)
Me
^  CO 
H,C Me
OC CO
^  ch2
+
H
or OH
OH
Diacetylacetone Orcinol
FIG. 1.2 Transformation of dehydroacetic acid 
(Collie’s polyketide hypothesis)
22Birch and Donovan suggested a possible relationship between
the biosynthesis of the fatty acids and the aromatic metabolites.
The key difference in the two pathways could be that the keto groups
along the chain are reduced in the formation of fatty acids but are
retained and undergo intramolecular condensation in the formation of
aromatic metabolites. Continuing the analogy with fatty acid
biosynthesis, they proposed that acetyl-CoA, rather than free acetic
23acid, is the C2 moiety undergoing condensation.
ry /
In 1957 Birch developed this theory more fully and provided
numerous examples of the manner in which it could be used to explain
A 25the formation of aromatic natural products. The current conception ’
( Fig. 1.3 ) of the biosynthesis of polyketide metabolites is that 
coenzyme A esters of acetic acid or other carboxylic acids condense 
with malonyl coenzyme A to give the thiol esters of 3 keto acids, 
which in turn undergo further Claisen type condensations with 
malonyl coenzyme A to give thiol esters of 3,5-diketo acids, 3,5,7- 
triketo acids (poly-3-triketo acid), etc. The polyketo acids can 
undergo a variety of intramolecular condensations to give aromatic 
systems. At the triketo stage four cyclisations could occur, two 
giving phenols and the others giving pyrones. Aldol closure between 
positions 2 and 7, followed by dehydration, would give orsellinic 
acid, while Claisen-type closure between positions 6 and 1 would 
give acetylphloroglucinol. Heterocyclic closures could give either 
tetra-acetic lactone, which is a 2-pyrone, or a 4-pyrone.
The polycarbonyl compounds can undergo a variety of modifications 
prior to cyclisation. Examples include reduction of keto groups to 
alcohols, and reactions of methylene positions with electrophiles,
0 0 0 0 0
^ S C o A  + H O ^ ^ ^ S C o A  l 5 2 ^  R ^ ^ ^ S E n z .  W '  V  ^ S C o A
0 0 
,XX
0 0 0
0 0
R
malonate
HO ^  ^  "" SCoA 
SEnz. ----— ----------► R
0 0 0 0 
A A A A SEnz.
(Tetraketide) 
Poly-3-triketo ester
Tetraketide
OH
OHOH
Aldol
Orsellinic
Acid
R=MeHO'
OH
OH 0
Claisen
Tetraketide -----►
OHHO
R
Acylphloroglucinol
OH
Tetraketide
R
0
0
4-Hydroxy-2-pyrone 
(Enol Lactone)
Tetraketide 4-Pyrone
FIG. 1.3 Biosynthesis o£ acetate-derived metabolites via polyketide 
intermediates 26
11
particularly with alkylation agents. After cyclisation other 
transformations can occur including changes of oxidation state, 
alkylation, halogenation and even cleavage of the aromatic nucleus. 
In cases where the polycarbonyl (poly-8-ketone) chain is long 
enough, multiple ring systems can be formed. Thus the biosynthesis 
of the great majority of naturally-occurring structures may be 
based on a few basic skeletal types, in conjunction with a variety 
of secondary transformations. The skeletal type formed will depend 
upon the number of C2 units incorporated, the starter unit (if it 
is not acetate), and the nature of cyclisation (aldol, Claisen or 
another type). Secondary transformations can be of considerable 
diversity (oxidation, reduction, ring cleavage, alkylation, etc.)
27Altemariol (1) is only one example of a range of heptaketide
28 - 2 9  . 3 0
metabolites, e.g. lichexanthone, griseofulvin, rubrofusarin,
31 32 33
flavasperone, 6-hydraxymusizin and barakol (Fig* 1*4)•
34
Thomas has suggested an alternative cyclisation mechanism 
involving poly-8-enolate chains which could generate the same 
metabolite, but without the direct mediation of ketonic inter­
mediates. This is illustrated ( Fig. 1.5 ) for the formation of 
orsellinic acid (O.A.). Accordingly, an enzyme stabilized poly-3- 
enolate (A) with the appropriate geometry undergoes electrocyclic 
rearrangement to an intermediate from which orsellinic acid is 
formed by a simple elimination process (path (b)). Path (a) shows
the conventional scheme for the derivation of polyketides from
22
poly-3-keto precursors.
OH
HO
OHMe
0
OHMe
WeMeO
(T) Altemariol
OMe OMe
MeO 0
Me
0
Griseofulvin
OH
MeO-
MeOMe
Lichexanthone
OH OH
CGMe
HO
6-Hydroxymusizin
OH
MeMe
OH
Flavasperone Barakol
0
OH OH
MeMeO
Rubrofusarin
FIGo 1,4 Natural products derived from a heptaketide intermediate
13
OH
path !aj/
1 Acetate 
+
3 Malonate
path !b
■Me
COSR COSR
COSR
Orsellinic
acid
OE H
COSR
FIG. 1.5 Cyclisation of polyketides
A direct extension of this mechanism can account for the 
formation of various carbocyclic polyketides. For example, in the 
case of the phenalenone nucleus, the precyclization intermediate 
(a) could undergo conversion to (b) in a single concerted cyclisation 
step ( Fig. 1.6 ). Subsequent elimination of water (or bound 
enzymes) would then yield the phenalenone. The actual geometry of 
cyclisation of any poly-$-enolate would be determined by the sequence 
of cis and trans bonds, the formation of which may be dependent upon 
the stereospecificity of the elimination of the thioester group from 
the polyketide intermediates, as shown in Fig. 1.7. The
14
significance of the concept in defining assembly patterns in
35polyketides has been discussed by Packter.
OE
OHOE HO
OE OH
FIGo lo6 Cyclisation of the phenalenone precusor
c
Me. C
SR
CO,
CH2
\
-CO-
COSR
ar
Me—  c C —  COSR
e  h,
cl0 
II
MeC-CH2-COSR
FIG. 1.7 Stereospecificity of polyenolate formation
HO H-R
Me 'cosr
cis enolate 
EO COSR
C =  C
Me^ ^Hg
E = Enzyme
Another mechanism which leads to phenolic metabolites is the
r
"Shikhnic acid pathway”. » The primary role of this pathway is to 
provide the essential aromatic-acids. The intermediates of the 
pathway can also serve as precursors of secondary metabolites.
Key intermediates include chorismic acid and prephenic acid, 
illustrated as follows:
15
COOH
Glucose • >  ».
HO'
OH
shikimic acid
COOH
0OH
CH2
II
c
OH
chorismic acid
COOH
HOOC CH2COCOOH
OH
prephenic
acid
NH2
1
phenylalanine
NH2 
.CH2CHCOOH
tyrosine
The first experimental evidence in support of the polyketide
hypothesis for the origin of aromatic rings was provided by 
37Birch et al who isolated 6-methylsalicylic acid (6-MSA) from
Penicillium griseofulvin grown in the presence of [l-1 C^]acetate.
16
The resulting labelling pattern was consistent with the derivation 
of its configurational carbon skeleton from acetic acid by sequential 
head-to-tail condensation ( Fig. 1.8 ). Similar results were
38-39
obtained later by Tanenbaum and Bassett in their studies of the 
incorporation of 14C-labelled acetate into 6-methylsalicylate by 
PeniciIlium patulum. Bu’Lock and Smalley^0 were later able to show 
that ll*C-malonate can be converted to 6-MSA by P. patulum.
Me
CoAS
CO;
■CH.
O ^ -
CoAS
o C02
/ *
CH2 COSCoA
'SCoA
CH2
I.
C02
Me
0
’COSCoA
C
H
Me Me
OH
COSCoA
OH
6-Methylsalicylic acid
FIG. 1.8 Incorporation of (l-llfC)-acetate into 
6-methylsalicylic acid
17
The biosynthesis of orsellinic acid from acetate labelled with 
14C and 180 in the carboxyl group has been studied by Gatenbeck and 
Mosbach.^ The distribution of 14C in the orsellinic acid was as 
expected (Mosbach, 1960), and 180 was also shown to be 
incorporated into the hydroxyl and carboxyl group (Fig. 1.9).
This provided evidence that the hydroxyl oxygens actually come from 
the carboxyl oxygen of acetate as would be expected if the carboxyl 
group of orsellinic acid is derived from an acetate carboxyl through 
a process involving esterification and hydrolysis.
4 MeCOSCoA
*.
CO.
*»•
CO.
'CH
'CH2-COSCoA
CO-Me
Tetraketide
intermediate
* *
COOH
Orsellinic
acid
FIG. 1.9 Incorporation of labelled acetate into the orsellinic 
acid
Birch et al, showed that griseofulvin could be formed by 
Penicillium griseofulvin from [l-14C]acetate by head-to-tail
A 3condensation and C-acylation. This was confirmed by Rickards, and 
Hockenhull and Faulds.^ The cyclisation yields the labelling
18
distribution as shown in Fig. 1.10.
7 MeCOSCoA
Ci.
0 0 0
SCoA
0
0
OMe MeO
MeO
Me
(±)-Griseofulvin
FIG. 1.10 Biosynthesis of griseofulvin from acetate
The methyl groups of the methyl ether moieties are derived 
from S-adenosyl methionine (denoted as Ci).
Two examples of apparently related oxidative ring cleavage during the
biosynthesis of polyketide metabolites are shown in Figs. 1.11 and
46-47
1.12. Penicillic acid (P.A.) is produced by a variety of fungi, 
and its polyketide origin was initially established through
42 48-49incorporation studies with l^ C-labelled acetate and malonate. *
19
Recently, a feeding experiment with 3H-acetate of high specific 
activity was used in conjunction with 3H-NMR (for the first time in 
a biosynthetic study) to establish the labelling pattern.50"*51 Re­
labelled acetate has similarly been used as a direct biosynthetic 
52
probe. These studies demonstrated the biosynthesis of penicillic
acid via a C(4)-C(5) cleavage of orsellinic acid (O.A.). It was
suggested that an electrocyclic conversion of the hypothetical
epoxide to an oxepin could account mechanistically for the
53observed distribution of 3H in C3H3C02H-derived penicillic acid.
Another example in the field of acetate-malonate derived
substances produced by both Penicillium and Aspergillus species is
54
the metabolite patulin which was shown to be a tetraketide. It 
has been proposed that the biosynthetic route involves m-cresol,
55-57m-hydroxybenzylalcohol, m-hydroxybenzaldehyde, gent is aldehyde
58_59
and phyllostine. Recently, isopatulin was identified as a
new intermediate in the patulin pathway. 60 The structure and its 
role as an intermediate is reasonably explained by a mechanism involving 
C(4)-C(5) cleavage of phyllostine as outlined in Fig. 1.12.
The acetate hypothesis received further early support
/A /*/
from the work of Thomas on the biosynthesis of altemariol and
other fungalmetabolites. He pointed out that altemariol can also 
theoretically be derived solely from acetate by head-to-tail 
condensation and cyclisation, without any oxidation, reduction or 
introduction of additional substituents to the basic skeleton.
Fig. 1.13 shows probable folding patterns and sites of 
incorporation of [l-14C] acetate. It has been shown that altemariol 
is, in fact, synthesized from one molecule of acetyl-CoA plus
O.A.
OMe OMe
OH
HO
iOH
Me
Hypothetical epoxide
OH
0 kMe
Oxepin
OMe
H02C H-
H
Me
M e O - C = = O H  
Me |
V  c1 Jc 0
H - ^ c ^  | ^ 0 ^
I OH
H
Penicillic acid
FIG. 1.11 An alternative epoxide scheme for penicillic acid 
biosynthesis
LL
OH OH
-CO
Me
6-MSA
'CH20H
OH
Gentisyl alcohol
OH
•OH OH
CH2OH
62
Epoxidon (phyllosinol). Phyllostine
HOv h COOH
0
CO
HO
Isopatulin
HO' OH
/ OH
c
H
OH
/2t h
0  CO
OH
Patulin
FIG. 1.12 An alternative epoxidescheme for the biosynthesis of
, -t. 61patulin
six molecules of malonyl-CoA.
The early promise of the Collic-Birch acetate hypothesis has been 
realised, and with the advent of 3H and 13C techniques we have the means 
by which, with remarkable facility, predictions may be directly examined 
without resource to degradative experiments. Some fungal metabolites studied 
by these techniques are the phenalenone deoxyherqueinone, ^ 6 penicdllic 
acid, ^  and three major metabolites of Datura stramonium.^
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1.2.3 Cell-free studies of the biosynthesis of phenolic polyketides
f\ 8Lynen and Tada first obtained a soluble extract from
P. patulum which was effective in synthesizing 6-MSA in the
69presence of NADPH. Light obtained a more active preparation of 
6-MSA synthetase and suggested its probable identity with the multi­
enzyme complex. Lynen and co-workers' 7 0 - 7 1 investigations indicate 
that in 6-MSA synthesis reduction occurs at the triacetic acid level 
before the final condensation with malonyl-CoA, as shown in 
Fig. 1.14.
Some other cell-free systems isolated include orsellinate
7  9synthetase from lyophilised cells of PeniciIlium madriti, and an 
active preparation from A. altemata capable of synthesising 
altemariol. 65 In each case there is evidence for a multienzyme 
complex as in fatty acid biosynthesis. The mannitol cycle was 
recently shown in cell free studies to play an important part in
7 9 *-7/
the metabolism of the fungus A. altemata. ~ Similar systems for
38the biosynthesis of patulin have also been described.
1.3 Metabolites of Altemaria
1.3.1 The toxicity of Altemaria metabolites
Alternaria species are common field fungi,responsible for a
75variety of plant diseases, e.g. Japanese pear black spot,
- tobacco brown spot, ^  early tomato and potato blight, and
77citrus seedling chlorosis.
25
Mycotoxin production by Altemaria is well established. Of the
Altemaria isolates from a variety of food crops, 90% were lethal to
78rats when fed after growth on a com-rice mixture. Similarly,
79of 212 Altemaria isolated from tobacco, 60% were lethal to mice. 
Altemaria spp. are also known to possess a wide range of antibiotic 
activity, and of 127 isolates, 86 were active against either bacteria,
yeast or moulds. 8 0 The toxicity of Altemaria metabolites summarised
81 82 by Harvan and Pero and studied by Lucas et al.
1.3.2 Structure of the metabolites 
The Altemaria produce a number of phenolic compounds 
representing a variety of structural classes such as dibenzo-a-pyrones, 
anthraquinones, tetramic acids and polypeptides. The structures of 
the known Altemaria metabolites are presented in Figs. 1.15 and 1.16. 
The most commonly occurring class of compounds are the dibenzo-a- 
pyrones and their derivatives: altemariol (1), altemariol methyl 
ether (2), dehydroaltenusin (3), altenusin (4), altenuisol (5), 
altertenuol (6), altenuene (7) and the altenuic acids (8).
87TABLE 1.3 Compounds produced by strains of A* altemata
Compound Formula Ferric chloride colour
Altemariol Ci ifHi 0O5 purple
Altemariol methyl ether Ci5Hi2O5 purple
Altenuic acid I Ci 5H1 i+Oe pale purple-brown
Altenuic acid II Ci5H14O8 pale brown
Altenuic acid III Ci5H1 40 e deep purple
Dehydroaltenusin Ci5H12O6 brown
Altenusin Cl 5H1 1+06 violet (evanescent)
Altertenuol Ci ifHi 0 06 green
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OH
HO
(1) Altemariol, C H 0 R=H
—  9 m  10 5
(2) Altemariol methyl ether 
C15H12O5 R=Me
/
H02C
(£) Altenusin, C15Hm06
0
OH
(7) (i)-Altenuene, C15H1606
Me
OH
HO
OMe
(3) (i)-Dehydroaltenusin 
C 15H12^6
HO ORx
(5) Altenuisol, G^HkjOb, Ri=H, R2=Me
(6 ) Altertenuol, C14H10O6, Ri=Me, R2=
OH
C02H
(§) (-)“Altenuic: acid II, CisHmOg
FIG. 1.15 Structures of the metabolites of Altemaria altemata
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R: 0
OH
R
OMeMe
0
Anthraquinone A Ri=R2=H 
Anthraquinone B R!=R2=OH 
Anthraquinone C Ri=OH, R2=H
HO
HO.
OMe
Me
Altersolanol A R=OH R=H 
Altersolanol B R=H R=H 
Bostrycin R=H Rd0H*=R.
OH
‘Me
Me
Me
Tenuazonic acid
HO
CH
H0‘
Me
Altenin 75
OH
OMe
H0H2C
H0H2C
Me
0 0
Me
CH.
Me
(9) Altemaric acid
/Me
C H =  C 
OCH2 N  Me
Me
HO
OH 0
Dehydrocurvularin.86
Zinniol 88
FIG. 1.16 Structures of the metabolites of various Altemaria spp.
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The molecular formulae indicate a close structural relation­
ship between these metabolites, but the precise biosynthetic inter­
relationship is not yet completely understood. Nevertheless, it is 
apparent that all of these dibenzopyrone compounds contain either a 
carbon methyl group or a methoxy group, or both, attached in each 
case to a Ci3-skeleton. 87
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Altemariol (1) and its methyl ether (2) are produced by most 
A* altemata isolates as well as many other Altemaria species; 8 ^ " 86
they are produced in rather large quantities accounting for up to
641390 of the dry mycelial weight of seme isolates. It is of
particular interest since, in addition to its rarity among known 
fungal products, it is also a diphenyl derivative. Furthermore, 
altemariol appeared to constitute a classical example of the 
acetate hypothesis. The origin of altemariol is apparently of 
fundamental importance in relation to the other phenolic products 
of A. altemata, shown in Table 1.3.
Altenuisol (5) and altertenuol (6) are closely related meta­
bolites of A. altemata and may in fact be identical compounds.
Q O
Thomas postulated the altertenuol structure based mainly on its
empirical formula and biosynthetic arguments. Altertenuol,
m.p. 284.5-285°C, forms a triacetate, m.p. 245°C. Pero et al
isolated altenuisol, m.p. 277-282°C; triacetate, m.p. = 210-
213°C, and proposed this differing structure based on the fact that
altenuisol failed to react with a molybdate ion, a property common
89to orthodihydric phenols, although a positive reaction was 
obtained after demethylation with hydriodic acid. The position of 
the methoxyl group was assigned by comparing the Pmr. shifts of
29
altenuisol and its triacetate with that of scopoletin and its 
acetate.8^
(±)-Altenuene.(7), (±)-dehydroaltenusin (3) and altenusin (4) 
are closely related metabolites whose structures have been 
determined by X-ray crystallography. Altenuene, Ci5Hi606, a toxic 
fungal metabolite from A. altemata, was isolated by silica gel 
chromatography of the mould extracts as colourless needles, with a
melting point of 190-191°C . The originally proposed structure
90 91
(7) was revised following X-ray analysis. This revised
92
structure is similar to that reported for (±)-dehydroaltenusin,
93
and subsequently for botrallin (1 2).
(±)-Dehydroaltenusin, C15H1206, is one of a series of related
0 phenolic compounds which has been isolated from extracts of the
87mould A. altemata. It was isolated by the adsorption of 
A. altemata culture medium on charcoal, followed by ethanol 
extraction. The resulting solution yielded dehydroaltenusin as yellow 
plates melting at 189-190°C. Thomas (1961) 8^  first suggested
that dehydroaltenusin was a lactone derivative of a monomethyl ether 
of a substituted $-resorcylic acid, and that this portion of its 
structure was identical to that of ring B of altemariol methyl ether. 
The crystal structure of (±)-dehydroaltenusin was subsequently
no
determined by direct X-ray crystallographic analysis. The
structural relationship of dehydroaltenusin (3) and altemariol methyl 
ether (2) is indicative either of their biosynthetic derivation from a 
common polyketide precursor, or of a sequential pathway such as
(1) -*■ (2) (4) -*■ (3), requiring the intermediate conversion of the
substituted resorcinol ring A in (2) to the corresponding catechol (4) 
as discussed later (page 151).
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0 0
OH
HO
OH
OH
HO
Ole
(1) (2)
HO
HO?C
(4)
OMe
Me^
OH
HO
OMe
0
The methylation of dehydroaltenusin (3) by treatment overnight
with ethereal diazomethane at 5°C afforded more than three 
94products. These observations suggested the formation of
a methylenedioxy group by the reaction mechanism shown in Fig.
1.17.
95Coon’ibe et al proposed an identical structure for altenusin (4) 
largely based on a structure for dehydroaltenusin which, however, 
differs from that established by X-ray analysis, i.e. (3). Altenusin 
was crystallized from chloroform extracts as colourless prisms,
melting at 202 -203 C, and shown to be interconvertible with
31
Me
OH
HO
OMe
0
Me COO
f  \
CH2-NeN
Me COOMe
OMe
CH2N2  >
\ //
OMe
FIG. 1.17 Methylation of dehydroaltenusin (3) by diazomethane
dehydroaltenusin by oxidation with ferric chloride or reduction with
87sodium dithionate.
These two metabolites were also isolated from the culture medium
Q O
A. kikuchiana by Kameda et al, they found that the physical
chemical properties of dehydroaltenusin closely resembled those of 
botrallin (12), a metabolite of Botrytis allii.^  They possess a common 
cross conjugated dienone moiety.
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0
Me
V0H
MeO.
OMeOH
0
(i) - Botrallin (12) 
Botrytis allii
Altenuic acid II, Ci5Hm08 (§), is one of three isomeric acids 
isolated from A. altemata.87 It was separated from acids I and III 
by its limited solubility in ether, and crystallized from aqueous 
dioxan as colourless plates melting at 245-246°C. Altenuic 
acid I and II are converted into altenuic acid III by treatment with 
dilute sodium hydroxide. The structure of altenuic acid II has been 
established by X-ray crystallography; 97 however, the structures of 
the isomers of altenuic acid I and III remain undetermined.
Structural considerations of altenuic acid II are consistent with the 
initial suggestion that the altenuic acids may be formed via
oxidative ring fission of a product related to altemariol or its
83methyl ether. Additional support for this biosynthetic scheme is
afforded by the presence of a catechol moiety in the structure
95proposed for its co-metabolite, altenusin. This could yield (8) 
following ring cleavage of the catechol ring in a manner closely
analogous to the known metabolic degradation of catechol leading to
98cis - cis-muconic acid and muconolacetone (Fig. 1.18).
OH
OH
0
Catechol
C02H
co2h
Cis, cis-Muconic 
acid
FIG. 1.18 Aromatic ring cleavage of catechol
0
Muconolactone
Diphenyl metabolites have also been isolated from plants, and 
even mammals (Fig. 1.19). Particularly interesting is the higher 
plant constituent autumnariol which is a deoxy-derivative of 
altemariol which was isolated from Eucomis autumnalis (Liliaceae).99
100
The well known cannabinoid constituents of plants such as 
cannabidiol are predictably of mixed acetate-mevalonate origin, 
whereas the derivation of the plant constituent sappanin101 is less 
certain. The possible biosynthetic relation of the Caster fiber 
pigments has been recently reviewed by Thomas.1
A second class of Altemaria metabolites are the anthraquinone
102 103pigments isolated from A. solani and A. porri. Anthraquinones A,B and C 
are substituted xanthopurpurins, and the altemariols which are partially 
reduced anthraquinones (Fig. 1.16). The biosynthesis of altersonal A, by 
Ac solani and its incorporation into altersolanol B and macrosporin has 
been studied by Stoessl et al.10^  Another reduced anthraquinone,
(1) Altemariol 
0
(4) Altenusin 
Me
C5Hh
(11) Autumnariol
Eucomis autumnalis
OH  OH
HOA A B />OH
Sappanin
Cannabinol
Ellagic acid
HD1HO OH
Castor fiber (beaver) 
scent glandpigments
FIG 1,19 Naturally-occurring diphenyl derivatives
bostrycin has recently been isolated from A. eichhomiae. 105
Tenuazonic acid is a tetramic acid derivative which is produced 
by th^  large variety of Altemaria spp.106[t was subsequently isolated from 
other genera*of fungi, viz.,Sphaeropsidales, and various Aspergilli.107
0 7
It was first isolated by Rosett in 1957 and its structure was
elucidated by Stickings in 1959,10?cf. Fig. 1.16 page 27 ). The synthesis
109 . . .  . .of the compound was described, and its biological activities
, 110 assessed.
Altertoxins I and II are metabolites of unknown structure and
are produced by A. mali 111 and A. altemata. Altertoxin I (C20H16OG)
is a yellow, amorphous solid. It fluoresces bright yellow under u.v.
irradiation, and this property has been used as a method of analysis.
Altertoxin II (C2oHit»06) is an orange, crystalline solid which melts
over a broad range (185-195°C decomp.) .• It is closely related to
81Altertoxin I and is probably a dehydro derivative.
Tentoxin (C22H30N4O5) is a phytotoxic metabolite of A. altemata
which produces chlorosis of several plant species. The originally
112 113proposed structure was revised to (10).
(10) Tentoxin
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Altemaric acid, C2iH30O8 (£) is a branched chain polyketide
produced by strains of A. solani, which are noted for their anti-fungal 
114activity. Its structure was established by Bartels-Keith and
Grove in 195911'* (Fig. 1.16 page 27 ).
Ergosterol and ergosta-4,6,8(14),22-tetraten-3-one (EtO) were
identified as metabolites of A. alternata isolated from Sorghum grain 
116and wheat. Although ergosterol has been considered to be a metabolite
common to all fungi (Weete, 1974) it was only recently isolated along
116with EtO. from cultures of A. altemata.
1.3.3 General and biomimetic synthesis studies 
118Hurtley (1929) condensed resorcinol with O-bromobenzoic acid 
in an alkaline medium with copper sulphate as a catalyst and obtained 
4'-hydroxy dibenzo-a-pyrone.
This reaction has proved to be of general applicability for the 
synthesis of substituted dibenzo-a-pyrones. It was extensively
studied and used by Adams and his collaborators in their synthesis
119 120of cannabinol, while Lederer and Polonsky (1948) condensed
orcinol (3,5-dihydroxytoluene) with 2-bromo-5-methoxy benzoic acid
to obtain 4’-hydroxy-4-methoxy-6,-methyldibenzo-a-pyrone. All of
these findings point to the conclusions that, when substituted
O-bromobenzoic acids are condensed in the Hurtley reaction with
orcinol, coupling takes place at the carbon atom in the orGinol
nucleus which is ortho and para to the two hydroxyl groups.
In an analogous manner altemariol was first synthesised by
37
coupling 2-bromo-4,6-dimethoxybenzoic acid with orcinol in the
2 7presence of basic copper sulphate. The resulting material on 
methylation yielded a compound which proved to be identical to 
altemariol trimethyl ether.
0
Me
LiO LiO
OMe
OR RO OR
Triketo-derivative f}
Me OH
NaOAc
HO
OHOH
0 0 0
HO
►HO OH
OHHO
FIG. 1.20 Biomime tic synthesis of altemariol (1)
A more elaborate synthesis of altemariol using dibehzyl
ether of methyl orsellinate and dilithioaceylacetone has been
121recently described. . (Fig. 1.20). This biomimetic synthesis of altemariol 
is based on the pathway, as shown in Fig. 1.21 .
The figure (cf. Fig. 1.21) shows two groups of natural products 
derived from seven acetate units via enzyme-bound derivatives of 
3,5,7,9,11,13-hexaoxotetradecanoic acid (A). The first group of meta­
bolites arises from A by analdol cycl is at ion between positions 8 and 13 and a
38
0 0 0 0 0 0 0
-OH
8:13 Aldol cyclisation
Me 0 0 0 0
OH
HO'
2:7 Aldol 
cyclisation
OH
Me
OH
HO OH OH'
OH
OH .Me
OH
OMe HOMeO'
Lichexanthone CO Altemariol
Fib. 1.21 Biogenetically modelled synthesis of heptaketide metabolites;
121altemariol and lichexanthone (cf. Harris et al 1977)
39
Claisen condensation between positions 1 and 6 . The second group is 
formed by two aldol cyclisations, one between positions 8 and 13 and 
the other between 2 and 7. Lichexanthone is an example of the first 
group and altemariol an example of the second.
Another synthesis of altemariol was carried out based on the 
alternate sequence of cyclisations (pathway (b) in Fig. 1.26) 
involving initial 2:7 aldol cyclisation of (A) (Fig. 1.22).
COoMe
OMe
OMe
MeN'\ <^OMe 
>0 
+
FSO3
pyrylium salt
0
Me
0
MeO
COoMe
MeO.
pyrone
Me
MeO
C02Me
(A) triketone
H0<
 Me N OH
(1) Altemariol
FIG. 1.22 Synthesis of altemariol by Leeper and Staunton (1978)122
Since altemariol can be selectively methylated to altemariol 
methyl ether, this constitutes a total synthesis of the methyl ether 
as well.
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By use of the appropriate benzoic acid analogues, this method 
could also provide synthetic routes to altenusin, dehydroaltenusin 
and altertenuol.
1.3.4 Biosynthetic studies
from seven acetate "C2 units" (cf. Fig.. 1.13 page22). This finding 
is equally consistent with the subsequently established acetate- 
polymalonate, since malonyl coenzyme A is itself derived from acetyl
original publication, two alternative theoretical pathways were 
proposed for the derivation of altemariol requiring either linear or
acetate-polymalonate pathway, the linear precursor would contain 
only a single acetate primer unit (i.e.. the C-methyl group of 
altemariol), whereas the branched chain mechanism would require the 
presence of two such acetate residues, as illustrated in Scheme 
The latter case would be analogous to the formation of citromycetin 
in Penicillium frequentans ( Fig. 1.24 ) as demonstrated by 
Gatenbeck and co-workers. 1 2 3
Me (1)
FIG. 1.23 Possible biosynthetic pathways for the formation of
altemariol. The thick lines indicate acetate primer units
CL
Thomas initially showed that altemariol (1) is assembled
coenzyme A through biotin-dependent carboxylation. In the
a branched chain C1 ^-precursor ( Fig. 1.23). In terms of the
41
Citromycetin
FIG. 1.24 The biosynthetic pathway for the formation of citro­
mycetin. The thick lines indicate acetate primer units
f\ sA study of the incorporation of [14 C]-malonate into altemariol 
by a cell free preparation from A. alternata subsequently confirmed 
its derivation from a single acetate-polymalonate chain (route (a), 
Fig. 1.23)
A possible mechanism for the formation of altemariol and other 
aromatic compounds of acetate-malonate origin, involves a multienzyme 
complex containing protein bound acetate and malonate units
42
appropriately oriented to generate a poly-3-keto acid covalently 
bonded to the enzyme through a thioester grouping (fatty-acid 
biosynthesis). The poly-3-keto intermediate may be bound to the 
enzyme surface by hydrogen bonds, the release of the final product 
from the enzyme surface possibly occurring at the moment of 
aromatization.
The enzyme complex responsible for altemariol synthesis\ has
65
been partially purified by gel filtration on Sephadex G-25.
This enzyme utilizes acetyl-CoA and malonyl-CoA as substrates but 
it is inhibited by an excessive concentration of either precursor. 
The optimal velocity was observed with a ration of malonyl-CoA to 
acetyl-CoA of 6:1 which corresponds to the hypothetical value 
required for the biosynthesis of altemariol from a single acetate- 
polymalonate chain. It was also demonstrated that the addition of 
S-adenosyl-methionine to the reaction mixture led to the formation 
of altemariol methyl ether.
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Sjoland and Gatenbeck further investigated the properties 
of the enzyme preparation and found that it would utilize propionyl- 
CoA instead of acetyl-CoA as the starter unit to form the ethyl 
homologue of altemariol ( Fig. 1.25 ), but no other acyl- 
coenzyme A ester was an acceptable starter.
Altemariol is particularly convenient for studies of the 
condensing enzyme (s) as no additional transformations such as 
oxidation, reduction or decarboxylation are required for its 
biosynthesis. The sequence of formation of the
individual rings is uncertain; however, the lactone is probably 
the result of a spontaneous reaction, as discussed later (Chapter 2).
1.Acetyl-CoA 
+
Malonyl-CoA
H0<
1 Propionyl-CoA 
+
Malonyl-CoA
\  / / ~ \  //
Me N OH
(1) Altemariol 
,0
HO
\\
CH2Me  DH
Altemariol homologue
FIG. 1.25 Biosynthesis of altemariol and its homologue
Two alternative pathways (a) and (b) for the formation of 
altemariol, by sequential cyclisation of a heptaketide, are 
represented in Fig. 1.26.
A^ldol-oyc
(a) 0
(b) HO
Aldol-cycl.
Aldol-cycl
\  &)/:8:13
0' Aldol-cycl
FIG. 1.26 Scheme showing alternative cyclisation sequences of 
heptaketides
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Pathway (a) was proposed by Harris et al;121 but Leeper and 
122Staunton et_ al_ have pointed out that on chemical grounds pathway 
(b) is equally attractive.
27The metabolism of altemariol methyl ether (2) could account 
for most of the other dibenzo-pyrone co-metabolites. of A. altemata 
( Fig. 1.15 ). It has been suggested that altenusin could
derive from (2), which in turn could lead to the formation of 
dehydroaltenusin (3) and altenuene (7) by oxidation and reduction 
respectively. Oxidation of the carbonyl-methyl group followed by 
decarboxylation would generate altertenuol (6), whereas oxidative 
cleavage of the catechol grouping of altenusin would lead to the 
formation of altenuic acid II (8) in a manner analogous to the 
degradation of catechol to cis-cis-muconic acid and the corresponding 
muconolactone ( cf. Fig. 1.18 page 33 ). This biosynthetic
interrelationship (Fig. 1.27) is discussed in further detail later 
in this thesis (page 145 ).
Acetyl-CoA
+  > 0
6 Malonyl-CoA
HO
(1) Altemariol
0
OH. OH
OH-
\\ //
Me OMe
HO
H0<
HOoC,
^  j  \  //
Me OMe
('2) Altemariol methyl ether
OH
/,
Me
H02C
Me \ qh
H02C7
HO?C- r\ //OMe
OMe
(4) Altenusin O’
Me ,0‘
0
(3)(1)-Dehydroaltenus in
Me.
i» IIIMIMI Ih -------
(7) (i)-Altenuene ho
H02C
(8)(i)-Altenuic acid II
(6) Altertenuol
FIG. 1.27 Possible biosynthetic interrelationships of the dibenzo- 
pyrone metabolites of the Altemaria
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1.4 Object of the present study
The object of the present study is to enhance our understanding 
of the biosynthesis of the phenolic metabolites of A. altemata and is 
described in two separate although interrelated chapters (2 and 3).
In Chapter 2, in connection with the major objective, it was 
decided to prepare a number of derivatives of altemariol in order to 
examine their possible effects on the further metabolism of altemariol.
In Chapter 3 various aspects of the growth of the mould A.alter- 
nata have been studied. The aim of this work is partly to elucidate 
the optimum conditions for growth and accumulation of the phenolic 
metabolites altemariol and dehydroaltenusin, and also to develop a 
technique for the rapid labelling of metabolites. Thin layer 
chromatographic and autoradiographic procedures were extensively used 
for the detection of these metabolites.
The possibility that altemariol is an advanced intermediate in 
the biosynthesis of its accompanying structurally-related dipheyl 
metabolites has been investigated. This study is particularly concerned 
with an examination of the biosynthetic interrelationship between 
altemariol and dehydroaltenusin. The present investigation utilises 
the incorporation of isoto pically-labelled precursors by growing 
fungal cultures, after, resuspension of the mycelia.
The successful utilisation of these experimental systems is well 
established. 125
\
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In addition since altemariol is also the probable precursor of 
some other phenolic compounds produced by this mould, the possible 
inhibition of the biosynthesis of these metabolites, including the 
mycotoxin altenuene, was examined through feeding selected derivatives 
of altemariol. One section of the work is based on the autoradio­
graphic examination of the biosynthesis of the metabolites of various 
strains of A. altemata, and also a comparison of two different genera 
Altemaria and Botrytis which are known to produce structurally-related 
phenolic metabolites.
The major findings are briefly summarized in the introduction 
to each chapter.
CHAPTER 2
THE PREPARA TION AND ST R UCTU R AL STUDY OF 
DERIVAT IVES  OF A L T E R N A R I O L
49
2.1 Introduction
In connection with the major objective which is the examination 
of the biosynthetic relationship of altemariol to other A. altemata 
metabolites, it was decided to prepare a number of derivatives, in 
order to examine their possible effect on the further metabolism of 
altemariol. The latter effect and associated inhibitory experiments 
are described in Chapter 3.
The major findings described in this chapter are outlined in the 
following summary.
A conspicuous feature of altemariol and its derivatives is the 
intense fluorescence associated with the tricyclic ring system. This 
fluorescence is lost on opening the lactone ring which allows the 
benzene rings of the biphenyl moiety to become non-planer.
The existence of ring-open and ring-closed forms is dependent 
upon pH, high pH favouring formation of the lactonic acid form. This can 
be demonstrated by fluorescence studies since this property is a 
characteristic of the tricyclic lactone; in addition the u.v. and pmr 
spectra of the two forms exhibit characteristic differences. The high 
intracellular pH of the mycelium (typically 8 - 9.5) favours the 
existence of altemariol in a lactonic acid form. (This is further 
discussed in Chapter 3.)
In this chapter possible mechanisms for the formation of the 
lactone ring are discussed.
The extent of methylation of the hydroxyl-substitutents of 
altemariol is shown to exert a major influence on the ease of formation 
of the lactone ring.
The chemistry of various bromo derivatives of altemariol and its 
methyl ether have been investigated; their probable structures are 
shown in Fig. 2.1. The most readily formed bromo derivatives have been 
identified as tribromoaltemariol (17) and its corresponding monomethyl 
ether (18). In contrast, bromination of the di and trimethyl ethers 
yields principally dibromo derivatives. These bromine substituents 
are easily replaced by hydrogen in the presence of Raney nickel.
During bromination of the ring-open form of altemariol (lactonic 
acid) in alkaline solution, a CO2H group is replaced by bromine.
These findings are now described in detail, in the present 
chapter.
(1) Altemariol Ri=R2=R3=H
(2) Altemariol monomethyl 
ether Ri =Me " H 2 =R3 =H
(13) Altemariol dimethyl ether
• R!=R2=Me R3=H
(14) Altemariol trimethyl ether
R1=R2 =R3 =Me
J
OH
HO Br
(15) 4-bromo altemariol
Br PH
HO Br
(16) Dibromoaltemariol 
R\=H, Rji=Br 
or R’^Br, R2=H
OR
OMe
Br
(17) 31,4,5f-tribromoaltemariol . (19) Dibromoaltemariol dimethyl ether
(Ri=H) R2=Me R3=H Ffi=Br Ffe=H
, s or R2=Me R3=H R'i=H R'2=Br
(18) 3’ ,4,5'-tribromo altemariol methyl
ether (R!=Me) (20) Dibromoaltemariol trimethyl
ether R2=R3=Me R'i=Br RV=H
or R2=R3=Me R'i=H R2=Br
FIG 2.1 Structure of altemariol and its derivatives
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2.2 Results and Discussion
2.2.1 Examination of the stability of the lactone of 
methylated derivatives of altemariol
27Raistrick et al (1953) showed that altemariol (1) correspon­
ded to 3,4',5-trihydroxy-6’- methyldibenzo-a-pyrone, and confirmed 
the structure by synthesis. The naturally-occurring monomethyl ether (2) 
was shown to have a methoxy group at the 5-position. Hence it was
t # y
identified as 3,4 - dihydroxy-5-methoxy- 6 -methyldibenzo-a-pyrone.
The structures proposed for both altemariol and its methyl
85ether have been supported by the studies of Freeman (1966).
A Dreiding model of altemariol (Fig. 2.2) shows the two benzenoid 
rings (A and B) to be non-co-planar, being forced slightly out of plane 
by the lactone ring. This predicts the existence of two enantiomeric 
forms one in which the carbonyl oxygen atom is above the B ring and the 
reverse. Thus two molecular structures are hypothetically possible for 
altemariol and each should be optically active, although because of 
the flexibility of the bicyclic ring system it is unlikely that these 
two enantiomeric forms would be sufficiently stable to permit their 
resolution.
As a consequence of their salicylic acid moieties, altemariol and 
its methyl ether exhibit intense purple ethanolic ferric reactions; 
they also fluoresce bright blue under uv irradiation (254, 350 nm).
Even the small deviation from co-planarity in altemariol presumably
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reduces the conjugation between the n-bonded systems of the benzene rings 
thereby reducing the fluorescence intensity of altemariol relative to 
that of fluorene and phenanthrene. 126-127.
Methylation of altemariol with dimethyl sulphate and potassium 
carbonate yielded altemariol trimethyl ether (14) which was shown by 
spectroscopic studies to be identical with an authentic sample.
On methylation of altemariol (1) under the nornal conditions 
for preparation of the trimethyl ether, but using only one mole 
equivalent of dimethyl sulphate, a partially methylated product was 
readily obtained, which on recrystallization proved to be identical 
with the naturally occurring monomethyl ether (2). Methylation under 
slightly milder conditions than that used for the preparation of 
altemariol trimethyl ether produced the dimethyl ether (15) as light 
feathery needles, melting very sharply at 186 - 186.5°; unlike the 
trimethyl ether this gave a strongly positive purple colour with 
alcoholic ferric chloride. The melting points of altemariol and its 
mono, di and trimethyl ethers decreased regularly as the number of 
methoxy groups increased.
During the methylation of altemariol by methyl iodide in dry 
acetone solution in the presence of anhydrous potassium carbonate, two 
methylated derivatives, firstly the mono- and then the dimethyl ether 
were obtained. Despite the use of conditions known to be suitable for 
complete methylation with dimethyl sulphate, methyl iodide only gave 
' rise to a partially methylated product, even on prolonged refluxing with 
a tenfold excess of the freshly distilled liquid. The selective
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methylation of the hydroxyl groups of altemariol by methyl iodide is in 
accord with \ the earlier observation by Thomas (1961).6 ^ From this 
result and the presence of mono- and di-methyl ether under the usual 
conditions for the preparation of the trimethyl ether, it appears that 
the ease of methylation of the three hydroxyl groups of altemariol falls 
in the sequence 5 > > 3, although this assumes that dimethyl sulphate
and methyl iodide me thy late in the same order.
The methylated product, altemariol dimethyl ether, appeared as
a very bright blue fluorescent spot under u.v. light at 350 nm with a
Rp value of 0.85 in a benzene : glacial acetic acid solvent system
(6:1 v/v). The melting point of this compound and of 4 -hydroxy-3,
/
5-dimethoxy-6 -methyl dibenzo-a- pyrone (21) (m.p. 293 - 296°) 
synthesised by Rais trick jet al,27 and later reported . by Soti et 
_al,1 2 8 and Leeper _et al;1 22 are widely separated. The two methoxy
0
OMe
HO
OMeMe (21)
groups in our derivation must therefore occupy the 4 and either the 3 
or 5 positions. The compound gave an intense purple salicylate-type 
colour reaction with ferric chloride suggesting that position 3 is 
occupied by a free hydroxyl group. The i.r. data also place the 
hydroxy group in ring B close to a carbonyl function since strong 
hydrogen bonding occurs (cf Table 2.1). It is therefore probable that 
its structure is 3-hydroxy-4 ’, 5-dimethoxy-6-methyldibenzo-pyrone (13).
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The general data and melting point correspond to the compound 
prepared by Freeman,85
TABLE 2.1 I.r. lactone absorption bands (cm”1) of altemariol 
and its methylated derivatives
Compound
Altemariol (1)
Altemariol monomethyl 
ether (2.)
Altemariol dimethyl 
ether (15)
Altemariol trimethyl 
ether (14)
Methyl altemariolate-tetramethyl 
ether (26)
Mass spectrometry and elemental analysis of (13) established the 
molecular formula as Ci6Hii*05. The mass spectrum exhibited a large 
molecular ion at m/e 286. Other major peaks appeared atm/e 272, 255, 
258, 244, 227 and 229.
The u.v. and nuclear magnetic resonance spectra of (13) were 
obtained and the results listed in Tables 2.2 and 2.3. In this work 
the following compounds were used ;
vmax (cm”1) of 
C = 0 group
1660
1650
1705
1650
1665
1650
1725
1720
FIG. 2.3 Altemariol and its methylated derivatives:
(1) Rx = R2 = R 3 = H Altemariol
(2) R2 = R3 = H Rj = Me Altemariol monomethyl ether
(13) R3 = H Rj = R2 = Me Altemariol dimethyl ether
(14) Rx = R2 = R 3 = Me Altemariol trimethyl ether
TABLE 2.2 P.M.R. parameters of altemariol (1) and its methyl 
ether (2, 13, 14) in CDC13 + DMSO-d6
Chemical shifts,Multiplicity and Coupling Constants:
(1) (2) (13) (14) °f
2.7 2 . 6 8 2.7 2.72 3 6 '-Me i
- 3.86 3.8 3.78 3 OMe )
)
)
)
) ;
- - 3.85 3.89 3 OMe
- - - 3.9 3 OMe
6.35(d, j=1.6Hz) 6.27(d,j=1.2Hz) 6.45(d,j=1.5Hz) 6.45(d,j=2.2Hz) 1 4-H
6.65(d,j =2.4Hz) 6.57(d,j=1.7Hz)
6.6-6.65 (2H.)
6,6(2H,s)
1 ) 
) 
) 
)
1 )
/ 7
3 ,5-H
6.7(d,j=2.5HZ) 6.65(d,j=1.7Hz)
7 -2 (d,j=l-7Hz) 7.15(d,j=1.3Hz) 7.2(d,j=1.5Hz) 7.18(d, j=2.2Hz) 1 . 6 - H
1 0 .2 , > 1 0 . 2 > 1 0 > 1 0 0 - H
'
The three D20 exchangeable protons at 610.2 (broad) for altemariol,
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and the high field protons, i.e. 1 0 ppm observed for altemariol 
mono and dimethyl were removed on D20 exchange.
Chemical shifts are in ppm relative to internal IMS. The 
numbering of atoms follows that of Fig. 2.3.
TABLE 2.3 Ultraviolet absorption spectra (in ethanol)of altemariol (1) 
and its methylated derivatives
(p
Xmax(nm) 
log e
341
(4.06)
333
(4.06)
300
(4.05)
289
(4.02)
278 258
4.71
214
4.34 .
(2)
A max 
log e
342
(4.06)
335
(4.04)
299
(4.02)
288
(4.02)
277 258
(4.68)
216
(4.34)
(13)
A max 340 330 298 287 277 256 218
log e (4.15) — (4.060 (4.06) (4.7) (4.5)
(14)
A max 
log e
335
(4.17)
329 301
(4.06)
289
(4.06)
279 256
(4.7)
2 2 0
(4.5)
The u.v. spectra for the four species are very similar.
Addition of alkali (1 drop of 2M-NaOH ) to an ethanolic solution 
of (1), (2), (13) and (14) affected some peaks. When NaOH was added 
to an ethanolic solution of altemariol (1), peaks appeared at 356, 
320, 309 and 281 nm. The spectrum returned to that indicated in the 
table on reacidification.
Altemariol monomethyl ether (2) in alkaline solution (2M-NaOH) 
exhibited peaks at 362, 318, 310 (v.w) 278 (sh) 265 and 217 nm.,
whereas the addition of a drop of lOM-NaOH caused the 
peaks at 313, 277 and 235 nm. to be reduced in intensity and that at 
217 nm. to be enhanced, whereas the peaks at 368 and 265 nm. remained
unaltered. The original u.v. spectrum was regenerated by the addition of
concentrated hydrochloric acid (2 drops). The u.v. spectrum of (13) in 
alkaline solution (addition of 2M-NaOH) to an ethanolic solution of (13) 
showed maxima at 354, 306, 294(w) 274 (s - sh) and 249 n.m.; the peak at 
220 nm. increased in intensity. The original u.v. spectrum was 
restored on addition of acid (3M - HC1). Addition of alkali to the 
solution of (14) produced no effect on the u.v. spectrum except to
increase the intensity of the peaks at 2 2 1 nm.
In general it seems that the ring open form (bicyclic lactonic acid) of 
altemariol is present in solution, when peaks at about 277 and 315 nm. 
are obtained. The peak at 277 run. vanishes as soon as the peak at 
265 nm. appears, and the aqueous solution fluoresces green under ultra­
violet light. Also, once the 265 nm. peak is present, the aqueous 
solution will turn pink on standing and then deep red. The altemariol 
solution with this red colour developed absorption peaks at 455, 296 and 
248 nm. This coloured material seems to be due to an oxidation reaction 
since, if kept overnight under nitrogen, the solution turned only a very 
pale pink.
Investigation to find the endpoints of the ionization of group, 
gave the same result as Sime’s.12^  As he reported, the first 
ionization occurs to give a species characterized mainly by absorption 
at 265 and 308 nm. with modifications presumably dependent upon 
structure. The second ionization is characterized by a species 
absorbing at ca. 360 and 240 nm. and the third ionization produces an
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absorption peak at 280 nm.
To investigate the solubility of altemariol at different pH 
values the aqueous solutions containing 2 mg of altemariol at pH 7.4, 
8.4, 9.6, 11 and 12 were stirred overnight. They were then filtered 
and assayed by ultraviolet spectroscopy. The concentrations of the 
samples were determined from the standard calibration curve with 
reference to the peak at ca 300 nm.
.if
pHO
•H
S3
E
CD
+->
rH
Ctj
mo
•H
pH
•H
HrHO
CO
100
10 11 12 13 14
pH
\
FIG. 2.4 Solubility (I) of altemariol in water at different pH values.
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When altemariol was stirred in an aqueous solution at pH 7.4 
and 8.4, it showed no sign of the characteristic ultraviolet absorption 
peaks due to the lactone ring open form. This result reflects the 
insolubility of altemariol in water at pH values below 8 .
Alkaline hydrolysis of altemariol and its methylated derivatives 
opens the lactone ring giving rise to products with the bicyclic 
lactonic acid form (Fig. 2.5) which in contrast to the parent lactones, 
do not fluoresce under u.v. light (350 nm). On tic the lactonic 
acids appear in a lower R£ region of the chromatogram than the 
tricyclic lactones.
FlG. 2.5 Lactonic acid forms of altemariol and its methylated 
derivatives
HO C02H
Me ORi
(22) Ri - R2 = R3 - H C13H7 (OH)^ COOH
(23) Rx = Me R2 = R3 = H C1 3H7 (OMe) . (OH) 3C00H
(24) Ri = R2 = Me R3 = H C:3H7 (0Mel2 .(OH) .COOH
(25) Ri = R2 = R3 = Me C13H7 (OMe)3.(OH).COOH
Their relatively simple u.v. spectra is compared with methyl 
altemariolate tetramethyl ether (26) in Table 2.4.
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(26) C1ItH70 (OMe) 5
Methyl 21:3:4’:5-tetramethoxy-6'-methyldiphenyl-2-carboxylate
The i.r. spectra o£ the lactonic acid and the tricyclic lactone 
compounds show carbonyl bands ranging from 1655 cm” * for hydrogen- 
bonded 6 -lac tones to 1720 cm 1 for the fully methylated products. As we 
expected there is no evidence for the presence of lactone ring-absorption 
in the hydrolyzed compounds.
The p.m.r. spectra of the bicyclic free acid (lactonic acid) forms 
have been measured. Table 2.5 . .  clearly shows the relationship 
between the position of the p.m.r. methyl absorption and the presence 
(or absence) of the lactone function.
The p.m.r. data for altemariol, its mono- di- and trimethyl
ethers when compared with the ring open (lactonic acid) form of related
compounds show the meta-coupled ring B-protons at approximately 6 > 6.30 
\ ■ 
and 7.2. These positions shift to about 66.2 and 6.4 when the lactone
ring is opened. A similar effect is observed for methyl protons,
which shift upfield from 62.77 in (14) to 2.04 in methyl-altemariolate
tetramethyl ether (26). This upfield shift is due to the increase in
the dihedral angle between two rings when the lactone ring is open.
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TABLE 2.5 P.m.r. shifts (p.p.m.) of 6-methyl and ring B protons of
the lactonic acid and lactone form of altemariol, and their 
derivatives in (CDC1 3).
Compound Ring B protons 4-H, 6 -H 6 *-Me
Altemariol (1) 6.35 7.20 2.7
Altemariol monomethyl ether (2) 6.27 7.15 2 . 6 8
Altemariol dimethyl ether (13) 6.45 7.20 2.7
Altemariol trimethyl ether (14) 6.45 7.18 2.72
Bicyclic lactonic acid:
Altemariol (22) 6 . 2 0 6.35 2
Altemariol methyl ether (23) 6.25 6.35 1.95
Altemariol dimethyl ether (24) 6 . 1 6.32 1.9
Altemariol trimethyl ether (25) 6.25 6.42 2
Methyl altemariolate 6.30 6.45 2.04
tetramethyl ether (26) 6.32 6.50 1.65 (d6-DMS0)
Methylation of the lactonic acid form (ring open) of altemariol 
and its methyl ethers (22 - 25) with an excess of diazomethane yields 
to the fully methylated ester C19H2 2 0 6 (26). The i.r. carbonyl 
absorption now occurs at 1720 cm \  The presence of five OMe singlets 
is apparent from the pmr spectrum. One of the OMe singlets 
appears to correspond to an ester function (63.52).
Methylation of altemariol. trimethyl ether. (25) with one
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equivalent of diazomethane showed on tic that the first methylated
namely the ester product, since it was not taken up by sodium 
bicarbonate solution, and was easily methylated to give the fully 
methylated product (26). This methylation (-COOH — » COOMe) 
occurred immediately after addition of the ethereal solution of 
diazomethane to the methanolic solution of compound (25). After 30 
minutes, a second spot appeared with an Rf value of 0.7 which 
corresponded to (26). The reaction was complete after a week.
amounts b) two-fold excess c) three-fold excess and d) large 
excess to solutions of (22) (23) and (24), different methylated 
products were obtained. The reaction mixtures were chromatographed at 
times ranging from immediately after adding the reagent up to two 
hours, at five minute intervals, overnight, and after a week. A 
comparison of the chromatograms showed, the first methylated product 
corresponded to the lactonic acid form of altemariol monomethyl 
ether (23) and the next observed spot is probably its related ester 
(R£ = 0.22). Since this compound appeared for both (22) and (23), 
whereas there was no sign of it in the reaction mixture of (24). In
product may correspond to Ci8H2 o06 (27) with an R^  value of 0.58,
RO COOMe
Me
(27) R = H 
(26) R = Me
On addition of an ethereal solution of diazomethane in a) equivalent
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the case of lactonic acid form of dimethyl ether (24) the first new 
spot which appeared with an value of 0.43 was very unstable, and on 
standing on the plate, changed to a fluorescent spot, but disappeared 
during the reaction. This is probably an intermediate in the 
formation of the later methylated product.
None of these methylated derivatives was observed to be 
fluorescent under a u.v. lamp at 350 nm. Furthennore, they all 
appeared at higher characteristic R£ values, than the corresponding 
lactonic acid forms (22, _23, 24 and '25).
During oxidation of lactonic acid form of altemariol (22) with 
potassium ferricyanide, two spots appeared on the chromatogram of the 
reaction mixture extracts, one of R£ value corresponding to altemariol 
with the same bright blue fluorescent spot at 350 nm. (i) and the 
other with a higher R£ value (close to the front) which exhibited a 
greyish-green fluorescence (ii). The u.v. spectrum of (i) was 
identical to altemariol (1) while (ii) showed absorption maxima at 
337, 225 (shoulder) and 210 nm.
A conspicuous feature of altemariol and its derivatives is the 
intense fluorescence associated with the tricyclic ring system. This 
fluorescence is lost on opening the lactone ring which allows the 
biphenyl moiety to become non-planar.
The behaviour of altemariol in its two tricyclic lactone and bicyclic 
free acid forms, indicates that it is the lactone ring which is 
responsible for the fluorescent character and that this is sensitive
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to pH. Since altemariol when stirred in aqueous buffer at pH = 8 
showed no sign of the characteristic ultraviolet absorption peaks 
due to the ring open form (lactonic acid) but was shown to be converted' 
into the lactonic acid to an appreciable extent at above pH = 9.
This implies that the ring clousure reaction occurs below pH 8 .
Formation of the lactone ring suggests a transition intermediate
in which the two benzene ring approach coplanarity. The presence of
ortho substituents (at C-2, 2’,6 ’) would be sterically unfavourable
to the formation of such a co-planar transition intermediate. However,
/
an intermediate containing a double bond between carbon 1 and 1 would 
confer the required coplanarity and any factors which would contribute 
to this would consequently be expected to favour lactone formation.
In the course of tic examination of the alkaline hydrolysis 
products of altemariol and its various methyl ethers, it was 
observed (page 8 8) that rapid spontaneous lactonisation occurre^ only 
in those derivatives with free hydroxyl groups at C-3 and C-41.
Such derivatives are capable of existing as conjugated carbonyl 
tautomers with a double bond between the two rings (cf. structures 28,
29 and 30) and this suggests possible mechanisms of lactonisation 
involving transition intermediates of this type (cf. Figs. 2.6a, 2 .6b).
(1) Altemariol (R=H)
(2) Altemariol monomethyl ether (R=Me)
,6a The hypothetical alternative pathways (a, b and c) of 
altemariol 6-lactone formation.
(* = C-2’ oxygen which is retained on lactone ring 
formation).
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In an alternative way intermediate (29) could undergo cyclization
/
by attack of the carbonyl group at C-2 via a$ - addition mechanism.
✓
Tnis mechanism would however require loss of the oxygen at C-2, in 
contrast to the base-catalysed ring opening of altemariol QL) in which 
hydrolytic cleavage of the lactone 0-CO bond is obligatory (Fig. 2 .6b).
FIG 2.6b B-Addition mechanism (requires loss of C-21 oxygen)
me alternative pathway (a) in Fig. 2.6a can be excluded, since
/
the hydroxy group in C-4 is not involved in this mechanism. Of the
remaining altematives; one (b), appears from inspection of molecular
models to provide a more favourable orientation of the C-2T hydroxyl
130—132ana carboxyl C=0 for the required ring formation. v
6 -lactone formation has also been reported through an oxidation 
cyclization by Chalmers and Thomson.133-13^  They proposed the’mechanism 
indicated in Fig. 2.7 involving an ionic rather than free radical
Oxidation with sequential formation of a spiro y-lactone dienone 
with ring expansion to the 6-lactone.
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v'fT'-O 
(oxidant) ^
.0
//
\\ /
FIG. 2.7 Oxidative cyclization of 4-substituted biphenyl- 
2-carboxylic acid.
2.2.2 The preparation and structure of brominated derivatives 
of altemariol and related methylated compounds.
In addition to 3,4, 5-tribromo-5-methoxy altemariol (18) 
which was previously prepared by Thomas , attempts were made to 
prepare mono- di- and tribromo derivatives of altemariol and related 
methylated compounds by various bromination procedures. The bromo 
derivatives which most readily formed were the tribromo substituted 
altemariol (17) and the corresponding methyl ether (18).
Mass spectrometry and elemental analysis of (17) and (18) established
the molecular formulae as CmHyBrsOs and Ci 5H9Br3 0 5respectively. The 
mass spectrum of (17) exhibited prominent molecular ion peaks at m/e 492 
(M), 494 (M + 2), 496 (M + 4) and 498 (M + 6), where M is the mass
corresponding to molecules containing only 79Br atoms. The characteristic
(M+2) (M+4) and (M+6) pattern indicates the presence of three bromine 
atoms. All the molecular ions lost 28 atomic mass unit (a.m.u.) 
corresponding to loss of C = 0, yielding four ions at m/e 464, 466,
468 and 470, with relative abundances of a tribromo derivative.
OH
HO
Br
(17) R=H, (18) R=Me
The mass spectrum of (18) showed a similar pattern with a
prominent base peak at 506 (79Br).
The i.r. spectra (Nujol) of (17) and (18) exhibit a common band 
at approximately 1660 cm ^  which corresponds to the lactone ring. The 
u.v. spectrum of (17) shows maxima at 210, 225, 252, 262, 388, 325,
335 and 371 nm in ethanol; after adding alkali peaks appeared at 
266, 295, 370 with a broad peak at 318“330 nm; . acidification of the 
solution produced an u.v. spectrum with maxima at 210, 225, 260, 295 
and 304 nm and a broad peak at 342-252 nm.
The pmr spectrum (d6 -DMSO ) of (18) showed resonances due to
one aromatic methyl group (6 2.85, 3H), one methoxy group (6 4.05, 3H) and 
the signal corresponding to one aromatic proton (67.25, 1H). The spectrum of
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(17)showed a large singlet (62.76, 3H) corresponding to one methyl 
group, and the singlet proton (67.33, 1H) assigned to a benzene ring 
proton. One of the phenolic hydroxyl protons appeared as a (1H) 
singlet at 6 = 12.07^  while a broad peak at 6 1 0 - 1 2 probably 
corresponds to the other two phenolic protons. These peaks were 
removed on exchange with D20. Hydrogenation of (18) (using Raney 
nickel ) yielded altemariol methyl ether (2) thus demonstrating 
the easy replacement of bromine by hydrogen. The dibromo altemariol
(16) was prepared by bromination of altemariol, but in very low yield. 
The mass spectra exhibited large molecular ion peaks at m/e 414 (M),
416 (M + 2), and 418 (M + 4). As anticipated, loss of 28 a.m.u. was 
observed, leading to loss at m/e 386, 388 and 390 together with the 
appropriate metastable ion group centre at 361.9.
Another brominated product obtained from the bromination of 
altemariol was the monobromo compound (15). The mass spectrum again 
exhibited large molecular ion peaks at m/e 336 (7i%r) and 338 (81Br), 
the M : (M + 2) pattern indicating the presence of one bromine atom.
The ratio of the relative probability of occurrence of peaks at 336 was 
0.505 and 338 was.0.494, corresponding exactly to literature f i g u r e s . 1 ^  
Microanalysis results confirmed the molecular formula C H BrO-.
' 15 1 1 5
The pmr spectrum of (15) (dg-DMS0) provides evidence that the 
proton resonating at 6 = 6.3 in altemariol had been replaced by 
bromine. The proton assignments are tabulated below:
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f3‘ -2^
'*♦' A 1"
■i— ^OH
(15).Rj = R2 = H
(16) Ri = H , R2 = Br or R2 = H, R[ = Br
(17) Ri = R2 = Br
TABLE 2.6 P.m.r. shifts (ppm) of altemariol (1) and its brominated 
derivatives (15) and (17) in d6-DMSO
Compound Ring A protons Ring B protons Me-protons
(3», 5!-H) (4-H/6-H) (6 *-H)
6.64 (d,J 1.6 Hz) 4-H 6.3 (d,J 2.5Hz) 
Altemariol (1) 2.70
6.53 (d,J 1.6 Hz) 6-H 7.05(d,J,2.5Hz)
6.65 (d,J 1.1 Hz)
Monobromoaltemariol 2.62
(15) 6.58 (d,J 1.1 Hz) 7.39 (singlet)
Tribromoaltemariol - 2.75
(17) - 7.33 (singlet)
The bromo-substituted bicyclic lactonic acid form of altemariol 
appeared as a mixture of three compounds (Aj , A2, Ag.) on a tl'c plate, 
of which A2 (R£ 0.86) was observed to be the main constituent. The u.v. 
spectra of Ax and A2 show maxima at 215, 227 and 270 (weak-shoulder)nm.
The characteristic (M + 2), (M + 4), (M + 6), (M + 8) and (M + 10) 
pattern in the mass spectrum of A 2 indicates the presence of five
7 ^bromine atoms, with a molecular ion for Br appearing at m/e 621 (M).
The parent compound probably decarboxylates with concomitant replacement
of C02H by Br (cf. page 83). This reaction shows a facile bromination
of the bicyclic lactonic acid form of altemariol (2 2), consistent
with the presence of unsubstituted carbon atoms ortho to the hydroxy groups.
The presence of m/e 542, 463, 384, 305 and 226 with the associated
isotope peaks, indicates stepwise loss of bromine from the molecular
ion.
In contrast to the readily formed tribromo derivatives of 
altemariol and its methyl ether, bromination of di and trimethyl 
ethers yield principally dibromo derivatives Q(19) and (2 0) 
respectively]] . In the mass spectra of the dibromo compounds (19) 
and (20), the characteristic (M + 2) and (M + 4) patterns indicate 
the presence of only two bromine atoms, parent peaks appearing at 
n\/e 442 (79Br)and 456 (7^r)respectively. The intensity ratio of the 
M : (M + 2) : (M + 4) ions is close to the expected value as shown 
below:
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Relative abundance of ions
m/e Found Required138
456 0.28 (M) 0.26
458 0.44 (M + 2) 0.50
460 0.29 (M + 4) 0.24
It was observed that the parent ions containing two bromine atoms, 
fragment with loss of a single bromine to form a metastable ion:
Metastable Parent Daughter
ion ion ion
-81Br312.26 460  379
81r
310.33 458 377
79t>
313.63 458 ~ ■ 379
79r
311.63 456 — 111
The molecular ions also lose Me and CO to yield peaks showing 
the appropriate relative abundances required for the formation of 
dibromo fragment ions.
The pmr spectrum (CDClg + d6-DMS0 ) of (19) provided conclusive 
evidence for the presence of dibromodimethyl altemariol. There are 
five peaks in the following positions, with their related integral 
values (Table 2.7). 0
(19) Rj = H
(20) Ri = Me
or R? = Br R3 = H
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TABLE 2.7 Pmr shifts (ppm) of dibromodimethylaltemariol■ (19) in 
CDC1 3 + d6 -DMSO.
Chemical shift No. of protons Assignment
2.95 3 6 *-Me
3.95 3 5 -OMe
4.05 3 4’-0Me
6.7 (s) 1 3’ or 5f-H
7.32 (s) 1 6 -H
The two protons at 6 = 6.7 and 7.32 represent the two aromatic ring 
protons and the three proton singlet at 6 = 2.95, the methyl group.
The methyl group and the two other 3-proton singlets at 6 = 3.95 
and 4.05 are assigned to the methoxy groups. The spectrum of this compound 
provides evidence that the proton resonating at 6 = 6 . 4 5 and one of the two 
protons with a chemical shift of 6 = 6.65 in (13)(cf. Table 2 . 2 page 57 ) 
have been replaced by bromine.To determine which of the latter positions 
had been brominated, the spectrum of the region was expanded. However, 
the fine splitting of the methyl resonance in the parent compound due 
to coupling with the ortho proton, was not observed for the bromo 
derivative, indicative of the presence of an ortho bromo substituent.
The pmr spectrum of (20) was essentially the same except for an 
additional signal due to the methoxy group. The position of groups 
in (2 0) are compared with the related signals of the parent altemariol
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trimcthyl ether (14) (cf. Table 2.9). The i.r. absorption of the 
dibromo compound is shown in Table 2.8. The u.v. absorption 
spectrum of (19) and (20) differ in alkaline and acidic solution 
(cf. Table 2.10).
TABLE 2.8 I.r. absorption bands (cm”1) of altemariol trimethyl ether
(14) and its dibromo derivative (20) in Nuj ol
(20) vinax. (cm”1) (14) vmax. (cm”1)
lactone 1738 1730
group
1720 1720
aromatic 1600 1610
ring
1590 1590
1572
1 5 7 0Cv.w.)
C-0 (stretch 
and hydroxyl 
bending)
not
clear
1280
1250
0
(14) Ri = R2 = R3 = H
(20) Ri = Br , R2 = H , R3 = Br
or Ri = Br , R2 =Br v R3 = H
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TABLE 2.9 Pmr parameters of altemariol trimethyl ether (14) and its 
dibromo derivative (20) in CDC1 3
(2 0). (14)
2.92 (3H) 2.73 (3H) 6 '-Me
3.95 (3H) 3.80 (3H) O-Me
4.02 (3H) 3.90 (3H) O-Me
4.05 (3H) 3.96 (3H) O-Me
- 6.44 (d,J 2.2 Hz) 4-H
6.76 (lH,s) 6.61 (2H,s) 3', 5f
7.31 (1H,S) 7.18 (f,J 2.2 Hz) 6 -H
TABLE 2.10 Ultraviolet absorption spectra of dibromo derivatives of 
altemariol di and trimethyl ether (19) and (2 0) 
respectively
Compound A max. nm;
19 (ethanol) 352 341 303 294 259 225,215
19 (plus alkaline) 374 315 305, n. vw 277sh 251 217
19 (plus acid) 352 341 303 294 259 225,215
2 0 (ethanol) 325 306w 293w 26° , 2 4 | h .225 207V
2 0 (plus alkaline) 3 2 ! w 305.vw 23Ssh 2 1 2vs
2 0 (plus acid) 325-335,„vw 286 2 1 2 vs
w = weak vs = very strong sh = shoulder
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The attempted preparation of dibromo-altemariol (16) by 
demethylation of dibromotrimethylaltemariol (2 0) using constant 
boiling HI, gave a compound, which based on pmr and chromatographic 
data appeared to correspond to altemariol (90% yield).
The reaction was stopped after 2 hours instead of the recommended 
8 hours required for demethylation. However, in spite of this the 
bromine was eliminated before the methoxy group. This was established 
by pmr which showed the presence of residual Ole in spite of the loss 
of bromine. It thus seems that this procedure (refluxing with HI) is 
not suitable for demethylation of the bromo compound, but is an effective 
means of reductively displacing bromine.
A tetrabromo derivative, m.p 220-222° possibly (34) was obtained 
(20% yield) during bromination of the lactonic acid (25) prepared by 
alkaline hydrolysis of altemariol trimethyl ether C17H1605 (14).
This was dissolved in aqueous NaHC0 3 (10%) prior to treatment with 
bromine water.
0
(16) Ri = H, R2 = Br 
or Ri =Br, R2 = H
The mass spectrum showed major molecular ion peaks at m/e 572, 574, 
576, 578 and 580. The relative abundance of the five molecular ions 
(corresponding to compain atoms of 79Br and 81Br) indicated the presence 
of four bromine atoms:
M . (i.e.79Br) (M + 2) (M + 4) (M + 6) (M + 8) ei
Peak height 
(cm.)
1.35 4.10 5.55 3.55 0.90 15.65
Peak height 
ratio found
0.0862 0.2620 0.3546 0.2268 0.5750
Required (Br^ ) 0.0654 0.2557 0.3794 0.2443 0.5970
Difference 0.0208 0.0063 0.0063 0.0175 0.0022
The results of microanalysis of the compound (34) and the mass 
spectrum required are consistent with the molecular formula C2 sH^Br^Oi*, 
requiring loss of C2H602 from C17H18O6 (25) during bromination. All 
the molecular ions lose 30 a.m.u. (CH20) to give ions at 542, 544, 546,
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548 and 550. The following additional fragmentations had appeared 
from the formation of metastable ions:
letastable Parent Daughter
ion ion ion
423.2 M -HBr 492
395.5 542 ■-Br - 463
347.6 492 •-Br 414
318.5 463 -Br 384
330 384 -CO 336
Examples of metastable ions observed in the mass spectrum of 
tetrabromine derivative (54) (only fragments involving loss of the
, 7 9
Br isotope are listed).
TABLE 2.11 I.r. absorption bands (cm *) of tetrabromine derivative 
(34). Spectrum measured in CHQ3 in KBr Cell (0.1 mm.)
-l
cm
C-0 . stretching; 1280
C -H bending 1250 (sharp)
Aromatic ring 860 (C -H isolated hydrogen)
Aromatic ring 15701600
H-bonded hydroxyl 3160
group
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As can be seen from Table 2 . 1 1 there is no evidence of a lactone 
group. The u.v. spectrum of (54) in ethanol shows maxima at 295 (broad 
peak), 263, 257, 251 (weak), 248 (shoulder), 230 (shoulder) and 216 nm. 
Addition of alkali to the ethanolic solution produced no effect on the 
u.v. spectrum but on acidification the peak at A 295 was more sharply 
resolved, possibly indicating some decomposition.
The pmr spectrum of (34) in CDCI3 (TMS standard) shows three 
signals, one at 6 = 6.475 (1H) which was assigned to an aromatic proton,
a second at 6 = 3.87 (6H) due to two methoxy groups and a third at
6 = 2.3 (3H) due to the C-methyl group. Hence during bromination a 
methoxy group is also lost in addition to decarboxylation. It was not 
possible on the basis of pmr data alone to establish the position of 
the four bromine atoms and the unsubstituted aromatic proton in this 
compound. However, ring A can probably be excluded as the site of the 
aromatic proton because of the facile bromination of this ring both 
altemariol and its methyl ether and also because in the starting material
(25) the only free hydroxyl group is located on this ring. Thus the
aromatic proton is more likely to be located in ring B.
From mass spectral data it is obvious that a G02H group has been 
lost, and that this carboxyl may possibly be replaced by bromine.
Although the reason for this ready displacement is not certain, it 
could conceivably occur by a mechanism involving bromination of ring B 
at C-2 prior to decarboxylation, with concerted demethylation of the 
ortho methoxy group at C-3 as shown.
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0
0 - ^
I OH Me
c Br Co*
 /
\
H+
Br. PH
Bromination of C-2 position could also occur after decarboxylation. 
In which case it would be expected that bromination of ring B would 
result in a symmetrically substituted product and since only one 
unsubstituted carbon atom remains, this would consequently be at C-*4, 
as in (34).
Br OH
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2.3. Experimental
2.3.1. Purification of altemariol QJ
Demethylation 27 : crude altemariol (10 g.) originally isolated
by acetone extraction of the mycelium of the mould A. altemata in 1965, 
was demethylated by refluxing (8 hours) with constant boiling hydriodic 
acid (75 ml.) in the presence of phenol (2 g.) to promote solubility 
and hence acid demethylation of any residual methyl ether component of 
the mixture. The HI contained a quantity of red phosphorous to reduce 
decomposition of HI. The product was recovered by filtration of the 
resulting precipitate, which was washed thoroughly with standard KI 
solution (10 x 100 ml.) to remove iodine, and then with boiling water 
(10 x 10 ml.) to remove any residual KI.
The dried product was dissolved in hot dioxan (3 g./150 ml.) by 
refluxing and the solution filtered through a sintered glass funnel.
The filtrate was allowed to stand overnight in a stoppered flask at 
room temperature. The resulting colourless needles were recovered by 
filtration, and washed with cold dioxan (10 ml.) prior to drying over­
night in a vacuum desiccator. The yield was 2.79 g.
The mother liquors were reduced in volume and a further crop of 
crystals harvested. The first crop was chromatographically homogeneous 
Utlc. silica gel GF^ sv > benzene/acetic acid (6/lQ, only altemariol 
being present, while the second crop contained a trace amount of
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altemariol methyl ether (2). Both samples melted at 345-346°C (decomp.)
(C14H10O5 requires: C, 65:1, II, 3.9. Found: C, 64.9; H, 4.01). An
ethanolic solution of altemariol gave an intense purple colour with
ethanolic FeCl3. The general properties and colour reactions of the
27product agreed with those described by Raistrick et al.
272.3.2 Preparation of altemariol monomethyl ether (2)
A mixture of altemariol (1 g.), anhydrous K2C03 (4 g.), methyl 
iodide (0.24 ml. diluted in 2 ml. acetone), and dry acetone (100 ml.), 
was refluxed for 2 hours, since tic £silica, benzene/acetic acid 
(6/lJ shows the maximum conversion of altemariol to its monomethyl 
ether after this time. The solution was then filtered hot and the 
residue washed with fresh acetone. The filtrate was concentrated, 
giving colourless needles which on recrystallisation from ethanol gave 
altemariol mohomethyl ether (0.7 g.) m.p. 267° (decomp.) (C15H12O5 
requires: C, 66.2; H, 4.4. Found: C, 65.9; H, 4.3%). The spectroscopic 
data appeared identical with those reported for altemariol methyl ether 
by Pero and Main and Seitz et al.
2.3.3 Preparation of altemariol dimethyl ether (13)
The reaction was carried out as in the previous experiment with 
0.5 ml. methyl iodide (2:1 molar excess) for 8 hours. The reaction was 
followed by tic. The reaction mixture gave a positive reaction with 
alcoholic FeCl3. It.was filtered hot and on cooling deposited clusters 
of feathery colourless needles (0.7 g. from 19 g. of altemariol).
The crude product was recrystallised from acetone, m.p. 186°C.
The dimethyl ether was only slightly soluble in cold ethanol and the
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solution gave a purple reaction with alcoholic FeCl3. The dimethyl 
ether gave a characteristically more intense fluorescence under u.v. 
lamp at 350 nm. than the parent compound (C16H.m05 requires: C, 67.13;
H, 4.89. Found: C, 67.01; H, 4.841).
2.3.4. Preparation of altemariol trimethyl ether (4) 27
A mixture of altemariol (0.1 g.), anhydrous K2CO3 (0.5 g.), and
freshly distilled dimethyl sulphate (1 ml.) in dry acetone (20 ml.),
was refluxed for 6 hours, after which time the acetone solution no longer
gave any colour with ethanolic FeCl3. The mixture was filtered and
the residue washed with fresh acetone. The pale yellow filtrate, on
concentration, gave clusters of colourless feathery needles (0.095 g.)
which on recrystallization from acetone gave altemariol trimethyl
ether as colourless feathery needles, m.p. 164-165°C, the melting point was
not depressed on admixture with an authentic specimen of the ether
Ci7Hi605 requires: C, 6 8 . ; H, 5.4. Found: C, 62.2; H, 5.61).
This nethylated product was also produced by long continued (14 days)
methylation with ethereal diazanethane of altemariol monomethyl ether
in dioxan solution under the conditions described by Raistrick et 
27al. It also gave no colour with ethanolic FeCl3.
2.3.5. Fractionation of altemariol and its methyl ethers
Isolation of altemariol monomethyl ether:
The 9 g. of crude altemariol monomethyl ether (biosynthetic 
product; extracted from dry mycelium of A. altemata) was Soxhlet
87
extracted with Et20. Monomethyl ether rich fractions (6.4 g.) were 
recovered by 12 hours extraction, and were further purified by 
recrystallisation from ethanol (2.865 g.). The product fiom the 
early extraction cycles was accompanied by a reddish contaminant.
An attempt to separate the mixture of altemariol monomethyl 
ether and altemariol dimethyl ether observed by methylation of 
altemariol, was made using silica gel column chromatography. The 
mixture was applied in ethanolic solution and chromatographed on a 
silica gel column (100-200 mesh) using 4% methanol-chloroform. The 
dimethyl ether of altemariol was eluted just prior to the monomethyl 
ether.
Thin layer chromatography as a most general method for analysis
of Altemaria metabolites was carried out on pre-coated silica gel
139GF254 thin layer plates (0,25mm). To obtain better separation by 
tl.c . different solvent systems were tried (cf. page 164). The best 
solvent system for the separation of altemariol and its methyl ether 
has been found to be benzene-glacial acetic acid (6:1; v:v) in which 
altemariol, mono, di and trimethyl ethers have R.£ values of 0.2, 0.48,
0.85 and 0.50 respectively.
These compounds under u.v light (254 and 350 nm,) all exhibited 
violet fluorescent spots. When the plate was sprayed with a solution 
of 1% vanillin in conc.HaSOi* and then heated for 10 minutes at 110° 
the phenolic component gave a violet colour.
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For quantitative purposes, the preparative chromatography method 
on silica gel GF2st* thin layer plates (0.5 to 1.0 mm.) gave satisfactory 
results, by elution of the corresponding bands with hot ethanol, 
followed by weighing the dried material, or a spectropho tome trie 
method (cf. page 166 an assay for altemariol).
2.3.6. Alkaline hydrolysis of the lactone ring of altemariol 
and its methyl ethers.
2.3.6.1. Isolation of 2 1 -hydroxy-3:4T: 5-trimethoxy-61 -methyl 
diphenyl-2-carboxylic acid ' (25). A solution of 
altemariol trimethyl ether (0.20 g.; m.p 164°C in methanol (40 ml.) 
and IM-NaOH (2 ml.) was refluxed for 4.5 hours in an atmosphere of 
nitrogen. After cooling the colourless solution was titrated against 
1M-HC1. The neutralized solution was concentrated to about 251 
volume, cooled, acidified (congo red) with 1M-HC1, and the colourless 
crystalline solid which separated was collected, washed with water and 
dried. The product (0.195 g.) consisted of heavy colourless plates, 
m.p 171-173° (Ci7Hi806 requires C, 64.1; H, 5.7; Found: C, 63.31; H, 
5.8011). The product is insoluble in water but dissolves in aqueous 
NaHC03. Its ethanolic solution gives no colour with ethanolic FeCl3.
The product could not be purified by recrystallization since all 
attempts yielded a product of slightly lower melting point which was 
not completely soluble in cold aqueous 2M-NaOH. The m.p 171-173 was 
depressed in admixture with altemariol trimethyl ether, m.p 162-4°.
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The same procedure was carried out to prepare 2’:3-dihydroxy-4': 
5-dimethoxy-6’-methyl diphenyl-2-carboxylic acid (24) m.p. 159-160°.
21,3,4'-trihydroxy-5-methoxy (23) and 2',3,4 *,5-tetrahydroxy 
diphenyl-2-carboxylic acid (2 2) were isolated in the same way, but 
these two are more sensitive to pH and oxygen (produce red colour) 
and easily converted to the parent compounds (lactone form) by 
standing on the chromatogram plate for a period of time.
In an attempt to purify the ring open (lactonic acid), the
#
mixture which was obtained after acidification of.the reaction was 
placed in aqueous NaHC0 3 (101) and shaken with ether. The acids are 
more likely to stay in the inorganic phase than the lactone form.
The inorganic phase after separation was acidified to pH=2 in an 
ice bath and extracted with diethyl ether. The extract was dried 
under a stream of nitrogen, and then dissolved in a small amount of 
methanol,tic ^ silica GF254 benzene: acetic acid (6/lQ shows a 
single spot in each case (R^  > 0.1, 0.12, 0.48 and 0.5 for lactonic 
acid forms of altemariol, mono, di and trimethyl ethers respectively), 
and they did not exhibit any fluorescence at 350 nm.
To study the stability of the bicyclic lactonic acid forms during
the running of the chromatogram in the solvent system, a chromatogram 
of the component was run in one direction, and again at right angles 
to this. This showed that the spots appeared to be stable at room 
temperature, but when the plate was heated at 1 0 0° for 1 0 minutes 
and then developed in the second direction, the lactonic acid was 
converted to the lactone form.
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2.3.6.2 Methylation of the lactonic acid compounds
The lactonic acid form was dissolved in methanol, then treated 
with an ethereal solution of diazomethane, in differing ratios equimolar 
proportional, two-fold excess, three-fold excess and a large excess 
of reagent (diazomethane). Of the methylated products obtained on 
concentration of the reaction mixture, none of them was observed to 
fluoresce under u.v lamp.
2.3.7. Attempted oxidation of altemariol with potassium 
ferricyanide
The bicyclic lactonic acid form of altemariol (22) (0.39 g.) 
in a solution of sodium carbonate (1.5 g.) in distilled water (100 ml.) 
was stirred at room temperature under nitrogen while a warm solution 
of potassium ferricyanide (1.39 g.) in distilled water (100 ml.) was 
added, and stirring was continued for a further 3 hours. Two drops of 
silicon antifoam agent were added to avoid excessive foaming. After 
acidification with conc. HC1, the reaction mixture was extracted with 
ethyl acetate. The yield of the product (greyish-green fluorescent 
with an value of 0.65) was low. This compound was unstable and 
difficult to study.
2.3.8. Bromination of altemariol
Altemariol (100 mg. = 0.38 m.mol.) was dissolved in a small 
amount of dioxan ( 2 ml.) and treated with bromine in glacial acetic
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acid (3 x 0.38 m.mol.). A crystalline precipitate was deposited almost 
immediately (132 g. dried wt.). Recrystallization from hot dioxan 
(2.5 ml.) gave tribromo-altemariol (17) (128.5 mg.) as colourless 
needle-like crystals, m.p 284-286 (decomp.) (CmH7Br305 requires:
C, 34.14; H, 1.42; Found, C, 34.21; H, 1.53%).
The reaction was also carried out with (1 x 0.38 m.mol.) and 
2 x 0.38 m.mol.) of bromine in glacial acetic acid. The pure colourless 
tiny needles of monobromoaltemariol (15> were observed to decompose 
at above 310° (C14H9B1O5 requires: C, 50.0; H, 26.73; Found, C, 50.21;
H, 26.61). Dibromo-altemariol (16) was obtained as colourless 
needles decomposing above 300°. The yield of products was 60 and 90% 
for mono and dibromoaltemariol respectively.
The bromination of the ring open (lactonic acid of altemariol) 
form was carried out in NaHC03 solution containing the compound with 
standard bromine water in the same way.
2.3.9. Bromination of altemariol methyl ethers
Altemariol monomethyl ether (60 mg.) in dioxan (4.5 ml.) 
was treated with saturated bromine water (6 ml.). The crystalline 
precipitate formed was separated by filtration, washed with water and 
dried. The product (93.7 mg.) of m.p. 294-238 (decomp.) was recrystallised 
from hot ethanol (5 ml.)to give tribromoaltemariol(18) (67.4 mg.) as 
colourless needle-like crystals, m.p 297-298 (decomp.) (Ci5H9Br305) 
requires; C, 35.74; H, 1.88; Found, C, 35.56; H, 1.77%) which
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135corresponded to the tribromo compound prepared by Thomas.
The bromination products of altemariol-di and trimethyl ether 
were obtained by bromination these compounds (100 mg.) in glacial 
acetic acid (2 ml.) or dioxan (5 ml.) with bromine in glacial acetic 
acid (1:2 mole/mole). A crystalline precipitate was deposited after 
a few minutes. Recrystallization from dioxan or ethanol gave dibromo­
altemariol dimethyl ether (19) (130 mg.) as tiny colourless needles, 
m.p 250-254° (decomp.) (Ci6Hi2Br205 requires: C, 43.44; H, 2.71;
Found, C, 43*51; H, 2.58%) and dibromo-altemariol trimethyl ether 
(20) (110 mg.) as colourless prisme crystals m.p 268-270° (decomp.) 
Ci7HiifBr20s requires: C, 44*.73; H, 3.08; Found, C, 44.97; H, 2.851).
2.3.10 Attempted demethylation of bromo derivatives
Dibromoaltemariol dimethyl ether (19) (100 mg.) was demethylated 
with HI (2 ml.) in the same way as described in 2.3.1, but it was 
accompanied with debromination and yielded altemariol (90%).
2.3.11 Debromination of tribromoaltemariol monomethyl ether (18)
The bromo compound (100 mg.) was dissolved in aqueous sodium 
hydroxide (2M, 10 ml.) and treated with Raney nickel alloy (100 mg.) 
added in small portions as rapidly as possible (excessive frothing 
can be controlled by addition of a few drops of ethanol). The Raney 
nickel was removed by filtration, the filtrate flowing into ice-cold 
conc. hydrochloric acid (5 ml.). Ether extraction of the filtrate
141
93
evaporation of the ether, and recrystallisation of the residue from 
ethanol afforded altemariol monomethyl ether (267° decomp.) (48 mg. 
yield).
2.3.12 Analytical methods:
A Koffler apparatus was used for melting point determinations.
The carbon and hydrogen analyses were carried out on a Carlo Erba 1106.
U.V. spectrophometers models nos. SP-800 and SP-1800 were used 
for optical density measurements. I.r. spectra were recorded on a 
Perkin spectra 157G grating infra-red spectrophotometer using potassium 
bromide plates or KBr cell (0.1 mm.). For solid sample a mull was made 
in nujol.
The mass spectrometry was carried out on an AEI, MS12 70 ev 
mass spectrometer, around 150°C. P.m.r. spectra were taken on a Bruker 
WH 90 P.m.r. spectrometer with tetramethylsilane as an internal 
standard.
CHAPTER 3
BI O S YN T HESI S AND M E T A BOL ISM  OF 
A L T E RNA RI OL D ER IVAT IVES
3.1 Introduction
The objectives of the present investigation may be divided into 
three overlapping studies:
1. Autoradiographic survey of ^C-acetate and 1 ‘’C-formate-derived 
metabolites.
2. Inhibitory effects of some altemariol derivatives on A. altemata 
metabolism.
3. The incorporation of altemariol methyl ether into dehydroaltenusin.
Discussion of these three aspects is preceded by a section devoted 
to a survey of the cultivation of A. altemata.
While specific aspects are considered under three individual 
headings, because of their obvious interrelationship, there is inevitably 
considerable overlap.
The major findings described in this chapter are outlined in 
the following summary.
The metabolites of different strains of the fungal species,
A. altemata, have been compared using autoradiographic techniques 
involving examination of the growing fungus with the radio-isotopically 
labelled primary precursors, namely (1-1^ C)-acetate and 1^ C-formate.
All of the strains which were examined showed qualitatively similar 
autoradiographic patterns producing altemariol (1), its methyl ether (2) 
and some other related metabolites. Quantitatively, however, these 
autoradiographic patterns appeared to be variable. The present 
results also revealed that foimate was the most potent precursor 
for mature mycelium (7 days’ growth) and acetate for younger mycelium
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(4 days’ growth).
The examination of A. altemata at varying stages of growth 
showed that the accumulation of altemariol (1) and its methyl ether 
derivative (2) increased proportionately up to 7 days. Subsequently, 
the concentration of these metabolites declined, while the formation 
of other phenolic constituents such as dehydroaltenusin (3) and 
altenusin (4) increased. Thus it appears that altemariol is the 
initial heptaketide phenol to be formed and that it is a probable 
precursor of other related phenolic metabolites of A. altemata.
It is rapidly consumed by certain (low altemariol-yielding) strains, 
the growth of one strain, T159, being markedly stimulated on feeding 
altemariol. These observations suggest that the very low level of 
altemariol in some of these strains may be a consequence of non­
accumulation rather than non-production.
Feeding of altemariol to a non altemariol-yielding culture of 
Botryt.is allii, led to the production of altemariol methyl ether 
© *  This fungus produces botrallin (12), which structurally closely 
resembles dehydroaltenusin (3). The similarity of autoradiograms of 
extracts of this fungus and those of A. altemata, obtained on feeding 
(l-1'tC) -acetate to resuspended mycelia, indicates a possibly close 
chemotaxonomic interrelationship between these two genera.
The growth of A. altemata was markedly inhibited by altemariol 
dimethyl ether (13) and trimethyl ether (14) at a concentration of 
5 mg./60 ml. medium, whereas at this concentration altemariol (1) 
and its monomethyl ether (2) were observed to stimulate growth. This
97
inhibitory effect at relatively low concentration,in contrast to the 
stimulating effect of altemariol and its monomethyl ether indicates 
a critical role for the free hvdroxyl substituent at C-4* of altemariol 
and its monomethyl ether.
Thin layer chromotographic investigation of the mycelium and 
metabolism solution extracts showed no reproducible specific effects 
when brominated derivatives of altemariol were added to the growing 
cultures of A. altemata, although marked inhibition of growth was 
observed. ,
As a consequence of these findings and the known pH dependent 
lability of altemariol (cf. Chapter 2) it was decided to examine the 
effect on dehydroaltenusin production of feeding altemariol, both in 
the form of the tricyclic lactone (1) and also the corresponding 
bicyclic lactonic acid (22). Feeding of the lactonic acid resulted 
in a markedly increased yield while the tricyclic lactone^  form had no 
apparent effect on the production of dehydroaltenusin. These findings 
were consistent with the results of autoradiographic studies of the 
products formed on incubating (01UGH3)-altemariol methyl ether, 
which demonstrated the considerably enhanced production of radioactive 
dehydroaltenusin on feeding lactonic acid (cf. page 143).
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3.2 Results and Discussion
3.2.1 Survey of Altemaria altemata*''cultures
In order to ascertain which strains of A. altemata would be best 
suited for use in this programme, a survey of the available strains of 
this mould was undertaken.
Eight strains of A. altemata were available from the collection 
provided by Professor R. Thomas, and these were submitted to a series 
of tests for growth and efficiency of incorporation 1 ‘C-labelled acetate 
(Table 3.1).
TABLE 3.1 Catalogue numbers of the cultures of A. altemata
Cultures of A. altemata
Thomas 
Collection number
Commonwealth Mycological Institute (CMI) 
Catalogue number
T19 - -
T20 - -
T21 CMI 89345
T139 CMI 89343
T149 CMI 89343 (L.S.H.T.M. 108)
T152 CMI 89344
T153 CMI 89342 (L.S.H.T.M. 94)
T159 CMI 89981 (L.S.H.T.M., 6)
These strains were maintained on carrot agar slopes.
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Conditions of growth
(a) Solid culture
Two solid culture media containing agar were inoculated with 
A* altemata; the observations relating to their growth are summarised 
below.
TABLE 3.2 Growth of cultures of A. altemata on various agar media
Medium Growth
Potato dextrose agar Requires approximately 2 weeks to achieve
(P.D.A.) reasonable growth, at 24°C in the dark.
Carrot agar Slopes are well established after 3 days, 
yielding dark and heavily sporing mycelium. 
(Normally grown for 7 days at 24°C in dark 
and stored at ca. 4° until required).
This summary holds good for all eight strains of A. altemata 
examined in this survey of cultures although strains T152, T21 and 
T139 appeared to give a much more dense growth, of dark mycelium.
The strains are listed below in order of rate of growth.
T152 > T21 > T139 > T149 > T20 > T19 > T153 > T159
• In some'carrot•agar cultures of strains T149 and T21 crystals 
were liberated into the agar, appearing as small localised deposits of 
white solid at the edge of the mycelium-agar interface. These deposits,
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which fluoresced bright blue under u.v light (254, 350 nm.) were 
investigated by Sime, who demonstrated that they consist of crystalline
I/O
altemariol.
Subculturing was carried out to provide cultures for trial 
experiments.
(b) Surface culture
Three different liquid media, the Czapek-Dox (C.D.) medium, Raulin- 
Thom (R.T.) and a mixture of Czapek-Dox and carrot medium (C.D.: carrot 
2:1, v:v.), were used to study the growth of A. altemata in surface 
cultures. Growth of all strains of the mould was superior on C.D: 
carrot medium to that observed on C.D. itself, while growth on R.T. 
medium was very poor and generally unsatisfactory. .Initial growth of 
the mycelium across the entire surface was followed by progressive 
thickening and darkening of the mycelial pad. On C.D: carrot and C.D. 
media the establishment of the culture required approximately one week, 
whereas on the R.T. medium, the process often took up to 2 weeks. 
Thickening of the pad formed on C.D.,and C.D: carrot media took place 
over the following 3 weeks, after which time the mycelium began to 
disintegrate. On R.T. medium, the mycelial pad never achieved the same 
density of growth as that obtained on C.D.: carrot or on the C.D. medium 
alone.
(c) Submerged culture
Growth of the fungus in submerged culture was rapid. Small hyphal 
nuclei were visible in the medium after two days' growth, which, then
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increased in size over the next 7 days until the medium was filled 
with a dense mass of mycelial spheres, typically 1 cm. in diameter.
The mycelial was fairly constant in the culture between 8 and 11 
days; the glucose concentration in the filtrate decreasing from 5% 
to less than 1% within 5 to 6 days. Again the growth on C.D.:carrot 
medium was much greater than that on C.D. and R.T. media for all 
strains which were examined. The following results were obtained 
after 7 days’ incubation of T139 on C.D. and C.D.: carrot media, and 
T149 on C.D. (containing 51 glucose) and a commercial C.D. (containing 
sucrose) media (Table 3.3).
TABLE 3.3 Effect of media on the growth of A. altemata T139 and T149 
Results show average of 3 flasks grown in submerged culture 
for 7 days at 24°
Culture Medium- Mycelial Mycelial ext. Finalculture Medium. . weight ^  (acetone)(mg) pH
T139 C.D. 0.2698 13.8 7.3
T139 C.D.:carrot 0.4915 30.1 7.7
T149 C.D. 0.4559 13 6.6
T149 C.D.
(5% sucrose
0.2279 6 7.45
instead of 
glucose)
Course of Metabolism of A. altemata strain T139
In biosynthetic studies a precursor is usually fed to the organism 
at a time when its synthetic activity is high. This can be determined 
by observing the rate of formation of the metabolite during the course
of fermentation. Firstly, 3 different strains of A. altemata, namely 
T139, T149 and T159 were grown on a C.D.: carrot medium and incubated 
on an orbital incubator at 24°C. The mycelial weight and pH were 
monitored and the mycelia and metabolism solutions extracted with 
acetone and CHC13 respectively (Table 3.4). On the basis of the 
resulting data T139 was then selected for detailed general studies of 
growth both in surface and submerged cultures (cf. Figs. 3.1 and 3.2).
TABLE 3.4 Comparative fermentations of A. altemata T139, T149 and T159
Growth in submerged culture on C.D.:carrot medium (6 days at 24°C)
Culture FiltratepH
Mycelial
weight
Myc.extract 
(acetone)
Filtrate
extract
(CHC13)
T139 , 7.7 411.5 mg. 45.1 mg. 7.2 mg.
T149 6.7 311.3 mg. 31.5 mg. 9.8 mg.
T159 7.6 255.1 mg. 34.0 mg. 11.2 mg.
The T139 and T149 were also selected for further studies in order to 
make available sufficient mycelium and culture filtrate for the 
recovery of minor constituents observed during chromotography of 
extracts of surface and submerged cultures. T149 produced altemariol, 
and its methyl ether, and T139, dehydroaltenusin in higher concentrations 
than the-other available cultures.
In Figs. (3.1 and 3.2) the surface and submerged cultures are 
matched in such a way that the curves of growth of mycelial weight with 
time approximately coincide. The absolute values of the parameters 
differ widely between cultures, as would be expected.
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FIG. 3.1 Course of submerged culture fermentation of A. altemata 
strain T139 grown on Czapek-Dox: carrot medium at 24°. 
Results show average of duplicate flasks
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FIG. 3.2 Course of surface culture fermentation of A. altemata 
strain T139 grown on Czapek-Dox: carrot medium at 24°. 
Results show average of duplicate flasks
The acetone extracts shown in the Figs. were previously washed 
with petroleum ether in order to remove lipids. Chromatographic 
examination showed the major constituent of the acetone extracts to 
be altemariol and its methyl ether. An ethanolic solution of the 
dried extract exhibited a characteristic altemariol spectrum. On the 
basis of comparative extinction coefficients the extracts was estimated 
to be 84% altemariol (or its methyl ether). In the case of submerged 
culture, altemariol concentration and mycelium weight appear to decline 
more rapidly with aging of the culture than is observed under surface 
conditions of growth. Further studies on the metabolism of A. altemata 
T139 are described later in this chapter in the course of the feeding 
experiments.
Thin layer chromatographic examination of extracts of both 
mycelium and metabolism solution showed that the submerged cultures 
produced mostly the same detectable products as the surface cultures, 
but in lower yield. In general submerged cultures were preferred for 
their more rapid rate of growth, metabolic activity and uniform behaviour.
3.3.2 Autoradiographic survey of 1^ -labelled acetate and 1 Re­
format e derived metabolites
Acetate is a primary precursor for many secondary metabolites,8,1^ 3”1^ 6 
generally classified as polyketides which in the case of A. altemata 
include altemariol, its methyl ether and fatty acid as described in 
Chapter 1.
Gatenbeck and Hermodsson 63 have reported that altemariol is 
formed from a single chain derived from one acetate and six malonate 
units. Therefore, when altemariol is biosynthesised from acetic acid
this is initially converted to acetyl CoA, which must then be carboxy- 
lated to form malonyl CoA in order to enable chain extension to occur. 
Thus it was of interest to examine the fate of the ltfC-labelled acetate 
during the metabolism of A. altemata. Autoradiograms obtained from 
mycelial and metabolism solution extracts of the mould, proved to be 
a convenient procedure for the facile detection of a variety of poly- 
ketide metabolites. An additional aim of these experiments was the 
elucidation of the optimum conditions for the incorporation of advanced 
precursors.
The different strains of A. altemata already mentioned, showed 
similar autoradiographic patterns, when freshly-grown mycelia were 
harvested after 4-7 days’ growth and re-incubated in the presence of 
llfC-labelled acetate. All of the strains produced altemariol, its 
methyl ether and other related metabolites, but in differing 
concentrations (cf. Figs. 3.3 to 3.6). As is evident from these 
Figs. autoradiography can be applied as a simple chemotaxonomic 
probe.
The efficiency of incorporation of 1IfC-acetate into mycelial 
and metabolism solution was determined by measuring the activity of 
the extracts (Table 3.5) in addition to the qualitative indications 
provided by the autoradiagrams.
The maximum incorporation of 1J*C-acetate by T152 and T139 
appeared in the mycelial extracts in contrast to T20, T149 and T153 
where the bulk of the activity was recovered in the metabolism 
solution extract. The results show that in some cases (e.g. T139) 
about 20% of active metabolites of the metabolism solution and
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3 Autoradiogram showing (1-1 4C)-acetate-derived mycelial constituents 
of A. altemata.
Strains T139, T149, T152 and T153 grown (4 days) on C.D: carrot 
medium in submerged culture. Aliquot of mycelium resuspended 
in water (1 g./2 ml.), then incubated with (1-14C)-acetate 
(5pCi/24 hrs./24°C) and extracts (acetone) chromatographed on 
silica plate (CsH6: AcOH = 6:1) prior to autoradiography
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FIG. 3.4 Autoradiogram showing (l-ll+C) acetate-derived mycelial 
constituents of A. altemata strains T19, T20 and T21. 
Conditions as in Fig. 3.3 .
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virtually 100% of the active mycelial constituents are recovered in 
the extracts.
In order to obtain optimum labelling conditions for the feeding 
experiments, resuspended mould mycelium of the strain T139 at 
different ages from 3 to 9 days old were treated with ^C-labelled 
acetate as in the previous experiment. Altemariol and its methyl 
ether were eluted from the silica gel plate with ethanol and the 
specific activities of the samples measured. Fig. 3.7 shows 
the specific activities of these products, as a function of the 
mycelial age. Despite individual variation it is clear that the 
optimum mycelial age for incorporation of acetate into both alter- 
nariol and its methyl ether by A. altemata T139 in a submerged 
culture is obtained after 5 to 7 days’ growth.
At this age the rate of altemariol production is maximal, i.e. 
the rate of synthesis exceeds the rate of metabolism by the greatest 
amount. The optimum age for production of altemariol is similar to 
that for altemariol methyl ether.
f i  ^Gatenbeck and Hermodsson have shown that the altemariol
synthesising and methylating systems are closely linked. They found 
that the same enzyme preparation which incorporates acetate and 
malonate into altemariol would also produce 1^ C-labelled altemariol 
methyl ether when a Cx precursor [S-adenosyl- (14CH3) -methionine]] 
was added. It appears that the purified enzyme solution also contains 
a highly active O-methyltransferase group, since in the presence of 
a Cj precursor the enzyme system methylated the altemariol which had 
been synthesised de novo from acetate and malonate.
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FIG. 3.5 Autoradiogram showing (l-1^ C)-acetate-derived mycelial 
constituents of A. altemata strains T159,121, T139 and 
T149
Conditions as in Fig. 3.3 , but using 7 days culture.
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FIG. 3.6 Autoradiogram showing (*4C)-acetate-derived metabolism
solution constituents of A. altemata strains T19, T21, 
T 139, T149 and T159.
Conditions as in Fig. 3.5 , but using corresponding 
filtrate extract (CHCl3/pH2).
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FIG. 3.7 The effect of age of culture on the uptake of (l-llfC)- 
acetate by resuspended A. altemata T139 mycelium. 
Mycelium (lg. wet wt.), incubated (a) 2 hr. and (b)
10 hr. with (1-1^ C)-acetate in H20 (2pCi/2ml.) prior 
to acetone extraction and fractionation (tic)
o 1 **Oactivity of altemariol 
o ^ C-activity of altemariol methyl ether
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FIG. 3.8 Comparative autoradiogram showing (I-1^ C)-acetate and 
formate-derived metabolism solution constituents of 4 
nata strains T139 and-T149.
Conditions as in Fig. 3.3 following incubation of 1 
mycelium with (l-llfC) acetate (5yCi/2 ml.) and (llfC)- 
(5yCi/2 ml.).
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FIG. 3.9 Autoradiogram showing (11+C)-formate-derived mycelial 
constituents of A. altemata strain T139.
Conditions as in Fig. 3.3 following incubation of (14C)- 
formate (2pCi/2 ml.) with resuspended mycelium of different 
age.
(*cf. page 144)
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Siine studied the relative incorporation of ll*CH3-methionone
and ^C-formate as a Cx unit precursor into altemariol, altemariol 
momomethyl ether, and lipids. He showed that methionine as a Cx unit 
precursor is more efficiently utilized than formate in the methylation 
of altemariol. On incubating 1^ C-malonate with a culture of T149 he 
observed that altemariol is labelled after only 3 seconds, whereas 
significant labelling does not appear in the methyl ether until 12 
seconds. Incorporation into other products required still longer 
incubation times.
In our study when lhC-formate was fed to a 7 day old submerged 
culture of A. altemata, incorporation into the labelled metabolism 
solution metabolites was more effective with strain T139 as shown 
in Fig. 3.8. This strain has also been shown to produce a greater 
diversity of metabolites in high concentration.
Results obtained on feeding of ^C-labelled acetate and formate 
to cultures of A. altemata of different ages are shown in Figs. 3-8,
3-9 and 3-10 (Appendix). It was observed that formate appears to be a more
efficient precursor than acetate when the mycelium is more than 7 days 
old, although the reverse was true for younger mycelium (4 days old).
3.2.3 Inhibitory effects of some altemariol derivatives on 
Altemaria altemata metabolism
Apart from the fact that acetate and malonate are incorporated 
into altemariol and its methyl ether by the mould A. altemata, little 
else is known about the advanced stages of this biosynthetic process.
As altemariol is probably a precursor of various structurally-related
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co-metabolites, it was considered useful to explore the effects of 
feeding derivatives, such as mono, di and tri bromoaltemariol to 
growing cultures of A. altemata.
The rationale of the selective inhibitor approach is based on 
the concept that selective inhibition of an enzyme by analogues of 
its normal substrate could arise as a consequence of the effect of 
artificially introduced.substituents binding at the active site. •
This is the general mode of action of antimetabolites and can result 
in reversible or irreversible inhibition. Thus a suitable substituent 
at a strategic site on an intermediate may inhibit the process 
involved in the normal biosynthetic conversion of this intermediate 
to a subsequent metabolite. 1
Recent experiments by Lari and Thomas1^ 8 have succeeded in 
demonstrating that penicillic acid production is effectively completely 
blocked in vivo by low concentrations of 5-chloroorsellinic acid. 
Furthermore, the blocking of this pathway leads to the accumulation 
of increased yields of normally minor metabolites which are established
precursors of penicillic acid, namely orsellinic acid, 3-methoxy-
149toluquinol and its corresponding quinone.
OH OMe Ole
H02C H2C ^ Me
0
Orsellinic acid 3-Methoxytoluquino 1 Penicillic acid 
(ring open form)
OMe OH
Penicillic acid (cyclic form)
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Since so-called secondary metabolites such as penicillic acid and the 
mycotoxin altenuene ( 7 ), a metabolite of A. altemata, are 
generally considered to be non-essential to cell growth and reproduction, 
it is possible that secondary metabolite production can be interrupted 
without necessarily killing the parent organism. Where the secondary 
metabolite is a plant toxin, selective inhibition of its biosynthesis 
would remove the phytopathogenicity of the normal disease-causing 
organism.
Me
.OH
HO
OMe/
(7) (-) -Altenuene
Alternatively, it may be possible by this means to ’’turn off” 
unwanted shunt metabolic pathways which compete for metabolic pools 
of key advanced intermediates required for the formation of 
industrially important microbial products, e.g. antibiotics.
Brominated derivatives of altemariol were fed to growing 
submerged cultures of A. altemata and a strain of the mould 
Penicillium herquei (used as a non-altemariol producing control 
culture)o Thin layer chromatographic investigation of mycelium and 
metabolism solution extracts showed no reproducible specific effects 
although marked inhibition of growth was frequently observed. The 
effect of these compounds are exemplified by the following observations.
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The bromine derivatives of altemariol (16, 17 and 18) were fed 
to a growing culture of strain T139 and their effect on growth was 
determined by monitoring the weight of mycelium and by chromatographic 
examination of extracts of both the mycelium and metabolism solution. 
The results (cf. Fig. 3.11) show the inhibitory effect of tribromo- 
altemariol (17) and its methyl ether (18) which completely inhibited 
growth of mycelium at moderately low levels (ca. 5 mg./60 ml. medium).
(15) Ri=Br R2=R3=H
(16) Ri=Br R2=H or Br, R3=Br or
(17) Ri=R2=R3=Br
When 10 mg .of dibromoaltemariol dimethyl ether (19) was added to 
the growing culture (60 ml.) of T139, the sample t.l. chromatogram of 
mycelial and metabolism solution did not differ noticeably from that 
of the control, but about 901 of (19) was recovered by preparative 
chromatography. Presumably its insolubility would largely account for 
its non-involvement in metabolic pathways. On the other hand dibromo­
altemariol (16) exhibited an inhibitory effect on the growth when
added under the same conditions (mycelial weight was nearly half of
*
the control).
In further studies of the inhibitory effects of the tribromo 
compounds (17) and (18), these were fed to growing submerged cultures 
of P. cyclopium and P. herquei as the typical non-altemariol producing
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FIG. 3.11 Inhibition of growth of A. altemata T139 by derivatives 
of altemariol. Substances were added at concentrations 
0.625, 1.25, 2.5,5 and 10 mg. to culture after 2 days1 
growth on Czapeck-Dox:carrot medium (60 ml./250 ml. flask) 
and mycelium harvested after further incubation for 5 days. 
Average results from triplicate experiments.
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cultures. At 10 mg./60 ml. of (17) and (18) growth of P. herquei ceased, 
whereas this concentration did not significantly inhibit the growth of 
P. cyclopium. Thus these brominated derivatives are unlikely candidates 
for the selective inhibition of A. altemata metabolism, since they also 
inhibit growth of non-altemariol producing mould (P. herquei). Two 
other bromo derivatives dibromoaltemariol (16) and dibromodimethyl 
altemariol (19) also inhibited the growth of P. herquei at 10 mg./60 ml. 
These should therefore probably be considered more as general inhibitors 
than selective inhibitors.
When dibromoorsellinic acid was fed to cultures of A. altemata 
T139 and T149, growth of these moulds was inhibited at levels in excess 
of 2.5 mg./60 ml. The results are shown in Table 3.6.
0
(18) Ri=R2=R3=Br R4=H
(19) Ri=Br- R2,R3=H,Br R„=Me
TABLE 3.6 Effect of dibromoorsellinic acid (DBOA) on the growth of 
A* altemata T149 grown on C.D. medium (7 days at 24°) in 
submerged culture
Flask
number
+DB0A
mg
Final
pH
10“1 xGlucose 
00
Mycelial 
wet weight 
(g)
1 control 0 6.2 - 0.9380
2 +10 4.1 0.5 -
3 + 5.0 4.1 0.5 -
4 + 2„5 4.2 0.3 0.1665
5 + 1.25 6.0 - 0.9548
Average results from 3 flasks
Dibromo-orsellinic acid when fed to cultures of P. cyclopium 
completely inhibited the growth of this fungus at 5 mg./60 ml. Penicillic 
acid was also completely inhibited when the inhibitor was added in a 
concentration of 0.625 mg./60 ml. Thus dibromo-orsellinic acid can 
also behave as a general inhibitor.
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FIG. 3.12 Effect of dibromoorsellinic acid (DBOA) on the growth 
of P. cyclopium. Inhibitor was added at concentrations 
0.07, 0.15, 0.31, 0.625, 1.25, 0.25 and 5 mg. to 
culture after 24 hr. growth at 24° on 5$ glucose/Raulin- 
Thom medium (60 ml./250 ml. flask). Mycelial weight 
6 days after incubation (average of duplicate flasks).
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Effect of altemariol and its methylated derivatives on the 
submerged culture of A. altemata
After some preliminary work on altemariol, a fact of major 
importance appears to be the different observations on feeding the 
closed and open lactone ring forms, the relationship of which was 
discussed previously in relation to the influence of pH in Chapter 2. 
The present section describes the influence of altemariol and its 
methylated derivatives on the growth of A. altemata. Altemariol (1) 
and its monomethyl ether (2) were observed to stimulate growth, where­
as altemariol di and trimethyl ether (13, 14) stopped growth 
completely at a concentration of 5 mg./60 ml. This inhibitory effect, 
at relatively low concentration, in contrast to the stimulatory effect 
of altemariol and its monomethyl ether indicates a critical role for 
the free hydroxyl substituent at C-4’0f altemariol and its monomethyl 
ether.
0
(1) Ri=R2=R3=H
(2) R ^ e  R2=R3=H
(13) Ri=R2=Me R3=H
(14) R1=R2=R3=Me
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The results obtained from feeding of these compounds to the 
cultures of A. altemata T139, T149 and T159 are present below.
Altemariol (1) and its methyl ether (2)when fed to the T159 
culture, showed less stimulatory effects on the mycelial weight than 
were obtained with strain T139 (Fig. 3.11, page 120 Table 3.7 page 131). 
Although strain T159 did not appear to produce significant quantities 
of altemariol it was considered that this could be because the rate 
of synthesis did not appreciably exceed the rate of its subsequent 
metabolism. To test this possibility, 50 mg. of altemariol was added 
to this culture,two days after incubation and the subsequent growth 
compared with that of control cultures. After seven days' growth the 
cultures to which altemariol had been added were darker in colour than 
the controls, and also appeared to have grown better. The results 
showed that the mycelial weight increase exceeded the weight of. 
altemariol added (ca. 271).
The mycelium extract from the cultures fed with altemariol 
was compared chromatographically with extracts of control cultures 
grown in the absence of altemariol. Quantitative measurements 
showed that the added altemariol was metabolised to altemariol 
methyl ether and that it also stimulated the production of other 
metabolic products, especially a blue fluorescent metabolite (R^  > 0.9). 
When altemariol methyl ether (2) was fed under the same conditions 
to T159 it slightly increased mycelial growth.
Varying amounts of altemariol were added to a series of submerged 
flasks inoculated with A. altemata (strains T139, T159); Penicillium 
herquei (T28) and Botrytis allii (T162) were used as non-altemariol
producing control cultures. The results of this experiment (Fig. 3.13) 
showed considerable stimulation of mycelial weight in the case of 
strain T159 (27%) compared with a lesser increase for B. allii (15%) 
and none at all for P. herquei. The mycelial extracts of B. allii 
showed a component similar to altemariol methyl ether (t.l.c.) which 
was absent in the control and in addition culture filtrate of both 
B. allii T162 and A. altemata T159 showed a common yellowish fluor­
escent metabolite (R^  < 0.1).
Autoradiographic studies of B. allii and A. altemata showed 
they produce very similar autoradiogram patterns, indicating a possible 
close taxonomic relationship between these two genera.(Fig. 3.14).
A fact of considerable potential importance is the existence of 
altemariol in both the planar tricyclic lactone (1) and bicyclic 
lactonic acid forms (22). A comparative feeding study of these two 
alternative structures was therefore carried out.
The results obtained on feeding these compounds to a series of 
growing submerged cultures of strains T139, T149 and T159 are shown in 
Table 3.7a. A significant result was observed for T139 (which is 
the highest dehydroaltenusin-yielding strain), which showed an increase 
of mycelium weight when altemariol was fed both in the lactone and 
lactonic acid forms. There was a notable increase in the latter (90%). 
The most marked effect of altemariol was seen in strain T139.
The strain T159 which is a non-altemariol-accumulating strain 
was observed in this experiment and in the previous one to effect the 
rapid metabolism of the added altemariol (tic). . This observation
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FIG. 3.15 Effect of altemariol on the mycelial wt. of 
A- altemata T139 and T159, B. allii T162, 
and P. herquei T28. Altemariol was added 
to a series of shaken flasks containing 
Czapek-Dox carrot medium on the second day 
of growth and incubated at 24°for following 
5 days.
* T159 containing altemariol monomethyl ether.
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FIG 3.14 Autoradiogram showing (1-1^ C)-acetate and (]4(H-formate- 
derived mycelial constituents of 6 days submerged culture 
of A. altemata T149 and B. allii T162.
Conditions as in Fig. 3.3. 1 - T162 plus 14C-acetate
2 - T162 plus 1 ^ C-fomate
3 - T149 plus 14C-acetate
4 - T149 plus ^C-formate
indicates that the negligible level of altemariol in this strain may 
be the consequence of its non-accumulation rather than non-production. 
The same result was previously reported by Sime.150
0
HD
Me OH Me OH
(1) Altemariol (lactone form) (22) Altemariol (lactonic acid)
The mycelia from the cultures fed with altemariol were extracted 
with acetone and the acetone extracts were compared chromatographically 
with extracts of control cultures grown in the absence of altemariol.
With strain T139 a strongly fluorescing metabolite with high Rf 
value (R^. > 0.9) was observed in cultures containing altemariol, which 
was absent in the control. The u.v (X = 220. nm,) and the mass spectrum 
(highest observed ion m/e 422) of this compound did not produce any 
obviously useful information. Chromatographic examination of the 
chloroform extract of the metabolism solution detected a greenish-yellow 
fluorescent metabolite (R^  0.6), the concentration of which was greatly 
enhanced in cultures to which the lactonic acid forai had been added.
The acetone and chloroform extracts of T149 did not produce 
chromatograms which were significantly different from that of the control.
However, in the course of an examination of T159, altemariol mono­
methyl ether and two orange fluorescent compounds (R£ 0.28 and 0.34) 
appeared in the mycelial extracts and further stimulation of the 
orange compounds resulted on feeding lactonic acid form of altemariol. 
These two orange fluorescent compounds may correspond to those 
reported by Sime, which were very unstable and an attempted isolation 
by preparative tic decomposed with loss of fluorescence. He 150 
reported the major fluorescence excitation frequency was 425 nm. while 
emission maxima appeared at 467 and 496 nm. These substances were 
also produced by control cultures of T139 when grown on C.D.medium, 
consequently it is not clear from these experiments whether the orange 
fluorescing metabolites are produced directly from altemariol or not.
Altemariol in its two forms was also added to the strain T139 
grown on C.D. medium both at the time of inoculation and on the third 
day of growth. The results are shown in Table 3.7b.
These results show the effect of altemariol on the growth of 
mycelium, from which it is clear that when altemariol was added to 
the culture medium at the start of growth, the tricyclic lactone form 
(1) is not very soluble while the lactonic acid (22) is unstable at 
this slightly acidic initial pH (_5). Consequently the best time for 
adding altemariol both in lactone ring open or closed forms is on the 
second or third day of growth when the pH has typically increased 
(more uniform and better growth)' to 7 and 7.6,respectively.
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The effect of feeding both forms of altemariol on the metabolism 
°f A. altemata was also examined autoradiographically in the presence 
of (x 4C)-acetate and foimate.
A major -difference was observed on feeding the lactonic acid 
which led to a marked increase in the production of the culture 
filtrate dehydroaltenusin (3) and altenusin (4), (cf. chromatogram 
in Fig. 3.15) in contrast to the lactone form which produced a 
negligible effect. This effect was clearly indicated by an auto­
radiogram of labelled products derived from (^C)-acetate and formate,, 
in Fig. 3.15. Feeding experiments with radioactive altemafiol and 
its methyl ether to the culture confirmed .the expected biosynthetic 
relationship between altemariol and dehydroaltenusin (3) as will be 
discussed in the fourth section of this chapter.
Me
OH
HO
Ole
(3)
The effect of the lactonic acid form of the di and trimethyl 
ether of altemariol P(24) and (25) respectively ] on the metabolism 
of T139 was examined by an autoradiographic study of products formed 
on incubating (^C)-acetate with resuspended mycelium, in the presence 
of these compounds. The results in Fig.. 3.16 (cf. page 181 Appendix).
clearly showed the inhibitory effect of these compounds relative to 
the control.
Generally, from these feeding experiments it appears likely that 
altemariol exists intracellularly as the lactonic acid form since it 
has more effect than the tricyclic lactone both on growth and further 
metabolism.
The lactonic acid as mentioned before is sensitive to pH and 
undergoes cyclisation to the lactone probably via the ring closing 
mechanism which was described in Chapter 2. This also provides a 
possible mechanism for the excretion of altemariol into the metabolism 
solution in amounts large enough to separate from the medium forming 
crystalline deposits both in liquid (surface) and agar cultures.
Further evidence supporting for this mechanism is apparent from
129the observation confirming the earlier finding of Simes on stirred 
altemariol with water at pH 9.5 the intensity of the ultraviolet 
absorption peaks characteristic of the lactonic acid structure rapidly 
appear while the rather weak absorption due to altemariol is lost.
It has been shown that the pH of the solution obtained on 
squeezing filtered mycelium from surface cultures is higher than that 
of the initial filtrate by at least 0.5 to 1.0 pH units. Consequently 
the pH within the cell may well be 9.0 or even higher. Since alter- 
■ nariol has been shown to be converted into the ring open form to an 
appreciable extent at pH 9.5, it is probably present as the free acid 
in the intracelular environment.
dehydroaltenusin
ALTERNARIOL 
METHYL ETHER
UNKNOWN METABOLITE
ALIENUSIN
ORIGIN
Ai A2 A3 Bj B2 B3
FIG. 3.15 Autoradiogram showing the effect of feeding altemariol both
in its lactone (1) and free acid (22) forms to the metabolism of 
7 days culture A. altemata T139. Mycelium (1 g. wet wt.) 
incubated (24 h.) in buffer (2 ml.) containing altemariol 
(5 mg.) (1) or (22) in the presence of (ll+C) acetate (5yCi) 
prior to extraction of mycelium (acetone) and acidified 
filtrate (CHC13).
Series A and B = mycelial and filtrate constituents respectively
1 - plus acetate
2 - plus lactone (1)
3 - plus lactonic acid (22)
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The lower pH of the extracellular solution would be conducive to 
the lactonisation of the acidic forms following diffusion from the 
mycelium, leading the accumulation-and eventual crystallisation of 
altemariol from the metabolism solution the pH of which is normally 
not in excess of 8. It thus appears that the ring closure step may 
well be a spontaneous pH-dependent effect rather than an enzymic 
process.
3.2.4 The incorporation of altemariol monomethyl ether into 
dehydroaltenusin (3)
As a result of previous findings it was decided to examine the 
effect of feeding (lltC)-labelled altemariol monomethyl ether [both in 
the form of its tricyclic lactone (2) and the corresponding bicyclic 
lactonic acid (23)~| on the production of dehydroaltenusin and other 
related products of A. altemata.
Strains differing in dehydroaltenusin producing ability were 
used in this study. Of an initial batch of eight cultures of A.alter- 
nata, strain T139 appeared to give higher yields of dehydroaltenusin 
as measured by the ferric chloride reaction of the culture filtrate 
and also autoradiographic examination (Fig. 3.6 page 112 ) in both 
surface and submerged cultures than the remainder.
Strain T149 produced dehydroaltenusin in surface culture after 
3 weeks’growth on C.D.-.carrot medium. Addition of (l4C)-acetate to a 
35 day-old mycelium of T149 followed by autoradiographic examination 
showed no evidence of incorporation, whereas for a 21 day culture, 
several radioactive zones appeared on the autoradiogram, one of them
137
corresponding to dehydroaltenusin. This metabolite was not observed 
with submerged cultures of this strain. Hence the choice of T139 as 
the highest dehydroaltenusin-yielding strain, and T149 as one of the 
poorest producers (in submerged culture).
Autoradiographic examination of metabolism solution extracts of 
submerged cultures of strain T139 showed the presence of dehydroaltenusin 
over the period of 6 to 11 days. It was observed that the maximum rate 
of production of this metabolic occurred after _8 days' growth 
(Fig. 3.17 page 182 Appendix).
The dehydroaltenusin isolated from these cultures showed ultra­
violet maxima at 217 (log e 4.53), 249 (4.1) and 300 n.m. (3.3) (in 
ethanol). The pmr spectrum (CDC13) showed one aromatic methoxy group 
at (53.9 (S,3H) and two meta-coupled protons at 66.63 and 66.74 (d, 1H 
each, J 2,3 Hz), a C-methyl group at 61.71 (S, 3H) and two olefinic 
protons at 66.70 and 66.28 (S, 1H each). This identity of this 
metabolite was also confirmed by comparing the tic data with an 
authentic sample of dehydroaltenusin.
As a consequence of the previous finding that altemariol and 
its methyl ether, especially in the lactonic acid form, stimulated 
the growth and metabolism of A. altemata, chromatographically homo­
geneous (0ll*CH3)-altemariol monomethyl ether was fed to strains T139 
and T149 at the biosynthetically active age of 23 days (for surface 
culture) and 7-8 days (for shake cultures) when the rate of production 
of dehydroaltenusin is at a maximum. The results showed that the 
lactone form of altemariol monomethyl ether (2) was not readily
incorporated into further metabolites. This is in contrast with the 
high incorporation of lactonic acid (23) into the dehydroaltenusin.
The incorporation of altemariol monomethyl ether into other 
metabolites using surface cultures of T139 is apparent from the 
autoradiograms of the (llfC)-labelled products (Fig.,3.18 and Table 3.8).
0
(*Me = lttCH3)
TABLE 3.8 Incorporation of (014CH3)-altemariol methyl ether (2) into 
resuspended mycelium of strain T139. Mycelium grown in 
surface culture on C.D.:carrot (23 days at 24°), was 
resuspended in H20 (lg./2 ml.) containing radioactive (2), 
then incubated for 24 hrs. at 24° prior to extraction of 
the mycelium (acetone) and filtrate (CHC13 at pH2) followed 
by tic (C6H6: AcOH = 6:1)
Sample
1 **0-activity 
d.p.m x 10"3 yCi
Starting material (2) 5286 2.38
unchanged (2)
(recovered from mycelial 
extract)
2801 1.261
unchanged (2)
(recovered from filtrate 
extract)
2060 0.927
total unchanged 4861 2.188
(ca. 92% starting 
material)
♦1
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.18 Autoradiogram showing metabolites formed on incubating
(O14CH3) altemariol monomethyl ether (2) with 23 day old 
resuspended mycelium of A. altemata strain T139 (1 g./2 ml.) 
Conditionsas in table 3.8.
Series A and B = mycelial and filtrate constituents respectively
1 - plus 1^ C-acetate
2 - plus 14C-formate
3 - plus (011+CH3) -altemariol methyl ether
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The autoradiograph of the (ll*C)-labelled products shows six 
components for the mycelial constituents (cf. Fig. 3.18). These were 
designated ai, a2, a3, a4, a5 and a6, where the b series (b2 to b7) 
were the corresponding components of the metabolism solution.
Components ai and bi, a2 and b2, a3 and b4, a4 and b5 and as and b6 
were chromatographically equivalent. The chromatographic characteristics 
of these compounds are shown in Table 3.9.
The radioactive metabolites a3, b3, b6, b5 and ai* are chromato­
graphically similar to the metabolites shown to result from labelled 
acetate and formate on controls, whereas a2(b2) and a3(bi+) appeared on 
the autoradiogram only when radioactive altemariol methyl ether 
was fed to the resuspended mycelium.
TABLE 3.9 values and fluorescent character of radioactive meta­
bolites derived from (01*tCH3)-altemariol methyl ether, 
in surface culture of A. altemata strain T139. Conditions 
as in Table 3.8
Substances: a i a 2 a 3 a4 a5 a6 b x b2 t>3 b^ b s b 6 b 7
R_£ value 0.4 0 0.4 6 0.5 5 0.5 8 0.6 3 0;7 3 0.4 0 0.4 6 0.5 0.5 5 0.5 8 0.6 3 0.7 6
Fluorescent 
character 
at 350 and 
254 mrio
greyish
-green
( 3 5 0 )
v.p
violet
- greyish - 
-green
(3 5=0!)
** v.p v.p 
(25 4)(25 4)
v = very p = pale
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RIG. -1.19 Autoradiographic demonstration of the incorporation (of the 
lactone form) of O1 ^ CHa-altemariol methyl ether (2) into 
other products by A. alternata strain T149. Conditions as 
in table 3.10.
Series A and B = mycelial and filtrate constituents respectively.
1 = plus ^C-acetate
2 = plus 0 1 ttCH3-altemariol methyl ether (2)
Incorporation of radioactive altemariol monomethyl (2) into 
further metabolites of strain T139 and T149 was examined autoradio- 
graphically using submerged culture. The results given in Table 3.10 
and Fig. 3.19 show only poor incorporation of this radioactive potential 
precursor (2) into dehydroaltenusin. On the other hand, when the (ll*C) 
lactonic acid (23) was fed to T139 the autoradiogram clearly demonstrated 
the conversion of altemariol monomethyl ether in this free acid form 
into dehydroaltenusin (Fig. 3.20) . The zone corresponding to the 
dehydroaltenusin was recovered from the plate and characterised by 
chemical and physical methods.
TABLE 5.10 Incorporation of (0 llfCH3)-altemariol monomethyl ether (2) 
by resuspended mycelium of strain T139. Mycelium, grown 
on C.D.-.carrot (7 days at 24°), resuspended in H20 (lg./2 ml.) 
containing llfC-(2), then incubated for 24 hra at 24°, prior 
to extraction of the resulting mycelium (acetone) and filtrate 
(CHCl3/pH2).
Sample total activity 
d.p.m x 1 0 “ 3 liG'i
Altemariol methyl ether 
(as lactone) (2)
3300 1.488
Unchanged (2)
(recovered from 
acetone extract)
2460
Unchanged (2)
610
(recovered from filtrate)
Total unchanged (2) 3070 1.382 
(93% starting material)
Dehydroaltenusin 50
143
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FIG. 3.20 Autoradiographic demonstration of the incorporation of014CH3- 
lactonic acid form of altemariol methyl ether (23) into 
dehydroaltenusin (3). Conditions as in table 3.10.
Duplicate series A and B = mycelial and filtrate 
constituents respectively.
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Other labelled mycelial constituents:
Three green-yellow fluorescent substances (called Gi, G2 and G3) 
were observed to be present in chromatograms of acetone extracts of 
the mycelium of A. altemata strain T139. In the standard solvent 
system, Gi, G2 and G3 had Rf values of 0.31, 0.47 and 0.6 respectively.
Following repeated chromatography of the extract and elution of 
the bands with diethyl ether only very small quantities were isolated. 
When any of the three eluates was taken to dryness and rerun, however, 
the other two substances were found to be present as well. Since this 
phenomenon was observed even after repeated chromatographic purification 
of the eluates, it was concluded that the three substances are inter­
convertible.
The mass spectrum of G3 showed a complex spectrum with major ions 
at m/e 576, 574, 353, 339, 313, 262 and 239. This substance was 
markedly labelled on feeding (J^ C)-acetate and formate to a culture of 
A. altemata. Labelling was also observed when the ring open 
altemariol methyl ether was fed to the culture. Chromatography of 
G3 partially purified by preparative tic in benzene-.acetic acid (7:2 
v:v) demonstrated that this spot is a mixture of two components with 
very close values. The one of the lower R^  was not fluorescent, 
and very unstable; on recovering from the chromatogram it soon ceased 
to fluorescence greenish-yellow, and when left on the plate for a few 
minutes it changed to a greyish-green fluorescent spot. Thus, it was 
suspected that it may be related in structure to the lactonic acid 
form of altemariol and may perhaps be a metabolic product of alter- 
nariol, or an intermediate in the metabolic pathway of dehydroaltenusin.
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It appeared as a labelled product, following incubation of the 
mycelium with radioactive altemariol methyl ether and always appeared 
with dehydroaltenusin on thin layer chromatograms of culture filtrate 
extracts.
The ultraviolet spectrum was measured by isolating a sample 
under nitrogen and storing in ethanolic solution under nitrogen for 
the period required to perform the measurements. Its major absorption 
peak was at 270 nm. The mass spectrum showed major ions at m/e 286,
279, 256, 239 and 313 ]cf. dehydroaltenusin, C15H1206, (3), M 288 and 
altenuene, Ci5Hi606, (7), M 292] .
The remaining discussion is concerned with the biosynthetic 
relationships of altemariol and its co-metabolites:
A Dreiding model of altemariol (1) shows that as a consequence 
of the non-planarity of the 6-lactone ring, the two benzenes are not 
co-planar, requiring the existence of two possible enantiomeric 
structures (Fig. 2.2 page 53). However, since the freshly isolated 
natural product shows no observable optical activity, it presumably 
occurs as a racemic mixture of both forms. For this to be so suggests 
that a non-enzymic lactonisation step may be involved in the normal 
sequence as complete synthesis on an enzymic template would be expected 
to favour the formation of one enantiomer. This would be consistent 
with the spontaneous cyclisation of an initially biosynthesised bicyclic 
lactonic acid (22), (subsequently referred to as the ring open form). 
Alternatively, one enantiomer could be formed in a stereospecific 
enzyme-catalysed step followed by a facile reversible inversion of 
configuration to form its mirror image product leading at equilibrium 
to a racemic mixture.
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If the enzyme template releases the ring open form, of altemariol as 
the normal metabolite, the ring closed form, which is frequently 
observed to accumulate in considerable quantities, could then be 
regarded as an artefact of A. altemata metabolism. An experimental 
examination of the . influence of pH demonstrated the stability of 
the ring open form at pH 9.5 (the intracellular pH). Furthermore, 
the feeding experiments using both forms showed that the ring open 
(lactonic acid) has a much greater effect on the growth and metabolism 
of A. altemata than the lactone form of altemariol. This acid is 
also incorporated (ca. 25% Fig. 3.20) into other metabolites, mainly 
dehydroaltenusin (3) whereas in the lactone form incorporation was. 
observed to be less than 8% (Table 3.10). These observations are in. 
accord with the supposition that altemariol exists intra.cellulary 
as the lactonic acid.
The A. altemata metabolites, (^ )-dehydroaltenusin (3) and 
(i)altenuene (7), represent two modified diphenyl products, in which 
the aromaticity of ring A has been lost through oxidation and 
reduction respectively (Fig. 3.21 ). An interesting feature of both 
products is their occurrence as racemic mixtures (despite the presence 
in altenuene of three chiral centres), since, as previously mentioned, 
the formation of both enantiomers is often taken as an indication of
the operation of a spontaneous (i.e. non-enzymic) process.
The formation of dehydroaltenusin (3) by oxidation of the
catechol ring of altenusin (4) is known to be a facile step which is
readily effected by aqueous ferric chloride. This is normally 
considered to represent an oxidative coupling process involving free-
H0 f/ii ah. • OMe (4) Altenusin c/ (38) 0Me
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FIG. 3.21 Racemic phenolic metabolites of A. altemata
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radical intermediates, such as (58) (Fig. 3.21). A similar 
oxidative lactonization of the carboxylic acid group has been shown 
to be involved in the oxidation of geodoxin to geodin hydrate,152 
and also in the oxidation of griseophenone A to dehydrogriseofulvin 
(Fig. 3.22 ) which contains a similar cross conjugated dienone 
structure to that present in dehydroaltenusin (3).153~15^
K3Fe(CN)6
Griseophenone A
MeOMeO MeO MeO
catalyc
hydrogenation
MeOMeO
Me -
Me
Dehydrogris eofulvin
(^ )-Griseofulvin
FIG. 3.22 Biomimetic synthesis of griseofulvin based on intramolecular
166coupling of a heptaketide (Scott )
A possible alternative enzymic mechanism could involve ionic oxi­
dation via an intermediate, such as the ortho-quinonene (39) (cf. Fig.3.21) 
which then forms both enantiomers of the cross-conjugated dienone 
dehydroaltenusin following a spontaneous 3-addition of the ring B-
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substituted carbonyl group. This would involve an unexceptional 
ionic oxidative pathway 155 , in contrast with the frequently non- 
stereospecific free-radical oxidative coupling mechanism discussed 
previously.
Kameda 'and Namiki156 studied the biogenetic relationship between 
these two metabolites (dehydroaltenusin and altenusin), and attempted 
an enzymic transformation of altenusin into dehydroaltenusin (3) in 
vitro, using peroxidases. They showed that altenusin (4) could
be converted into dehydroaltenusin' (3) by the action of the oxidase 
from potato. They therefore suggested that such a conversion was also 
brought about by a similar enzymic system of Altemaria spp. and that 
consequently dehydroaltenusin is a metabolite of A. altemata and is 
not an artefact .
The molecular conformation of dehydroaltenusin (3) on X-ray
Q 2
crystallographic analysis by Thomas et al_ showed that it is largely 
planar £(3) corresponded to one enantiomer J and contains an intra­
molecular hydrogen bond of 2.59 A0, which appears to have induced some 
strain into the lactone ring as indicated by the long C(6’) to 0(9) 
bond of 1.477 (2) A0. This would be consistent with the observed 
ready cleavage of the bond during the reduction of dehydroaltenusin 
to altenusin with sodium dithionite.
OH
HO
OMe
(3)
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The structural similarity of dehydroaltenusin (3) and alter- 
nariol methyl ether (2) is indicative either of their biosynthetic 
derivation from a common polyketide precursor, or of a sequential 
relationship,
Altemariol (1) --» Altemariol methyl ether (2) --->
(1)-Dehydroaltenusin (3) -- > Altenusin (4)
or
Altemariol (1) --» Altemariol methyl ether (2) —
Altenusin (4) — > (i)-Dehydroaltenusin (3) ,
requiring the intermediate conversion of the substituted resorcinol 
ring A in (2) into the corresponding catechol (altenusin).
The experimental work on this sequence, mainly on the conversion
of altemariol methyl ether (2) to dehydroaltenusin (3) shows that the
lactonic acid form of altemariol methyl ether (23) is more readily 
incorporated into dehydroaltenusin than is the lactone form (2). 
Consequently, the pathway could follow a sequence not involving the 
lactonic form:
viz. Lactonic free acid (22) or (23)  » Unknown intermediate
Dehydroaltenusin (3) — > Altenusin (4)
0
The biotransformation of altemariol to altenusin requires a 
net 1,2-shift of hydroxyl, corresponding to the conversion of 
resorcinol to catechol, for which there is apparently no known 
precedent,
Different hypothetical pathways may be considered for the bio­
synthesis of dehydroaltenusin or altenusin from altemariol requiring 
related intermediates. One of these (a) involves interconversion via 
an oxidation-reduction sequence and another (b) the reverse. In 
addition an epoxide (pathway c) intermediate is conceivable which would 
not necessarily involve a change in the oxidation level:
OH OH
Resorcinol Catechol
OH OH OH OH
HO(> J U  *(a) (y -■} Altenusin (4)
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Although the removal of a phenolic hydroxyl by the reductive pathway
(b) has no precedent among monobenzenoid metabolites. A possible 
analogy may exist in aromatic poly carbocyclic metabolites, e.g. 
conversion of 1,3,8-trihydroxynaphthalene to 1,8-dihydroxynaphthalene 
by a pathway involving, in effect, the reduction removal of a phenolic 
hydroxyl group.157
Another hypothetical pathway (Fig. 3.23 ) for the conversion 
of altemariol methyl ether, as lactonic acid (23), into altenusin 
(4) involves oxidation, and rearrangement via the y-lactonic hemi- 
quinone (37) and the epoxide (35) to form the isomeric y-lactonic 
hemiquinone (36) which could then undergo ring expansion to give 
dehydroaltenusin (3).
The first step in Fig. 3. 23 requires y-lactone formation, and 
some support for this view comes from the analogous formation of 
griseofulvin (cf. Fig.3.22 page 14B). Another analogy is the synthesis 
of geodoxin from the corresponding O-carboxy diphenyl ether through 
an intramolecular oxidative coupling reaction. 158
The second step is the reversible formation of an epoxide 
intermediate. The epoxide formed is similar to that involved in 
the metabolic pathway for the conversion of phyllostine to patulin 
(Fig. 1.12 page 21). The hypothetical dehydroaltenusin epoxy precur­
sor (35) rearranges to the hemiquinone intermediate (36). This 
y-lactone structure (36) corresponds to that proposed by Coombe et al . 
for dehydroaltenusin in contrast to the more stable 6-lactone
92structure (3) as determined by direct X-ray crystallographic analysis..
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FIG. 3.23 An alternative scheme for the biosynthesis of the 
(±)-dehydroaltenusin
Formation of 3,4-benzocoumarins by oxidation and cyclisation of 2’-
133substituted diphenyl-2-carboxylic acid provides an analogy for
6-lactone ring formation, which the cyclisation reaction may occur
via the ring formation and rearrangement of the spiro-intermediate
159(y-lactone) for which the analogy exists.
This scheme (Fig. 3.23) would require the derivation of altenusin 
from dehydroaltenusin by an enzymic reductive step, for which there is 
a facile chemical analogy (i.e. dithionite reduction) as described 
earlier in this chapter.
90Pero et al during his work on altenuene (7) concluded that it 
is probably biosynthesised via altemariol methyl ether (2). If 
dehydroaltenusin is a precursor of altenuene then the subsequent 
enzyme-catalysed stereospecific reduction steps would be required to 
introduce two adjacent chiral centres with the appropriate relative 
configurations shown in (7). If this enzyme can utilise as alternative 
substances both antipodal forms of (±) -dehydroaltenusin (3), then it 
could conceivably account for the observed production of both 
enantiomers of altenuene. This is, however, unusual and intrinsically 
less likely than a pathway involving the spontaneous (i.e. non-enzymic) 
generation of one or more of these centres of asymmetry.
Altenusin or dehydroaltenusin probably serves as a precursor of
the three co-existing optically inactive isomeric altenuic acids I, II
87 9 7and III. One of which, (1)-altenuic acid II (8), has been shown
to contain two chiral centres. As previously indicated (Fig. 1.18
page 33 ) it appears likely that the actual enzymically-formed
metabolite is the corresponding cis, cis-muconic acid, which then
undergoes spontaneous 3-additions of the carboxyl groups. This could
give rise to all three optically active altenuic acid isomers.
FIG. 5.24 An alternative biosynthetic pathway to botrallin (12)
The close structural similarity of dehydroaltenusin (3) and 
botrallin (12) (with corresponding cross-conjugated dienone 
structures) is indicative of their biosynthetic derivation from a 
common polyketide precursor, such as altemariol methyl ether 
(lactonic acid, 23). In the case of botrallin this would require 
a two stage oxidation, involving conversion of the substituted 
resorcinol ring A of altemariol methyl ether, via a pyrogallol 
inteimediate (Fig. 3. 24 ) together with a selective methylation 
step.
Structural considerations together with the labelled precursor 
incorporation data are consistent with the following scheme (Fig.3.25) 
for the biogenetic interrelationships of the above metabolites.
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FIG. 3.25 Possible biogenetic interrelationships of altemariol,
altenusin, dehydroaltenusin, altenuic acid II and botrallin
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3.3 Experimental
3.3.1 Composition of media
(a) Raul in-Thom medium (R.T)
The Raulin-Thom medium used had the following composition: 
D-glucose (50 g), tartaric acid (2.67 g), ammonium tartarate (2.67 g), 
diammonium hydrogen phosphate (0.40 g), potassium carbonate (0.40 g), 
magnesium carbonate (0.27 g), ammonium sulphate (0.17 g), ferrous 
sulphate heptahydrate (0.047 g) and zinc sulphate heptahydrate 
(0.047 g), dissolved in 1 litre of distilled water. The initial pH 
of the medium was 3.8.
When used for surface cultures, 350 ml of the medium was dispensed 
into 1 litre flasks, while for shaken cultures (submerged cultures)
60 ml was placed into 250 ml flasks. The flasks were plugged with 
non-absorbent cotton wool and sterilised by autoclaving at 15 lbs 
per square inch pressure for 20 minutes.
(b) Czapek-Dox medium (C.D)
This medium contained D(+) glucose (50.0 g), sodium nitrate 
(2.0 g), potassium dihydrogen phosphate (1.0 g), magnesium sulphate 
heptahydrate (0.5 g), potassium chloride (0.59 g), ferrous sulphate 
heptahydrate (0.01 g), in" 1 litre of distilled water. Distribution 
of the medium into flasks and autoclaving was carried out as for the 
Raulin-Thom medium above. The initial pH of the medium was 4.6.
When growth on the Czapek-Dox medium takes place, the pH of the 
medium rises,while growth on the Raulin-Thom medium produces no such
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effect. The reason for this is the difference between the nitrogen 
source of the two media. In the Czapek-Dox medium, the nitrogen 
source is nitrate ion whose metabolism involves the release of 
hydroxyl ions which increase the pH. In the case of the Raulin-Thom 
medium, the nitrogen source is ammonium ion, whose metabolism releases 
hydrogen ions so that there is no tendency for the pH to rise.
A commercial Czapek-Dox medium(BBL) was used in some experiments. It 
differs from the one described above in having sucrose as its carbon 
source and in being buffered to an initial pH of 7.3. It was found 
unsatisfactory for the growth of A. altemata (cf. Table 3.3).
(c) Carrot medium
Carrots (300 g), washed and sliced, were boiled for 45 minutes 
in water (7 litres). The mixture was macerated, filtered through 
muslin, and glucose (20 g) was added to the hot filtrate whose volume 
was made up to 1 litre with distilled water. The initial pH of this 
medium was 5.1. The medium was dispensed and sterilised as for the 
previous media.
(d) Czapek-Dox:carrot (C.D.:carrot) medium
A mixture of the Czapek-Dox and the carrot medium (2:1 v/v) 
was found to produce the best growth of A. altemata (Table 3.3 page 101). 
The initial pH of this medium was 5.0.
(e) Solid media
The potato-dextrose-agar (PDA) medium contained potato extract
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(prepared by boiling potato slices, 200 g in 1 litre water for 
45 minutes), 2% glucose and 2% agar. The mixture was dispensed 
(10 ml)., when hot,into culture tubes and autoclaved. These were 
allowed to cool on a sloped surface to obtain a large nutrient 
surface area. Czapek-Dox agar slopes were made from a Czapek-Dox 
medium containing 2% agar. Carrot agar slopes were prepared similarly 
to the PDA slopes.
In preparing the carrot medium, carrots (300 g) were used instead 
of potatoes.
3.3.2 Techniques of inoculation
(a) Slopes from slopes
This was carried out by transfer of spores on a wire from a 
sporing slope to another in sterile surroundings. Slopes were 
incubated for a period of ca. 7-8 days which allowed sporing from the 
fungi. The growth of the culture on the carrot agar slope was rapid. 
Initially, the growth of the mycelium was pale in colour but, after 
about 3 days, the culture darkened and began to form spores. By the 
fifth day, a heavily sporing culture was produced.
(b) Flasks from slopes
Sterile distilled water (ca. 10 ml) was poured onto a heavily 
sporing slope, the surface of the slope was scratched with a wire, 
and the tube shaken vigorously. An aliquot (ca. 3 ml) of the spore 
suspension was then poured into the flasks under sterile conditions. 
The flasks were kept in an incubator at 24°C for growth in the
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surface culture. For the submerged culture, the flasks were placed on 
a Gallenkamp incubator orbital shaker (240 rpm) at 24°.
Satisfactory surface cultures grew only slowly and it took 
about 8 days for the mycelial pad to establish itself across the 
whole surface. The mycelium, initially pale in colour, darkened to 
black at about the same time it established itself across the whole 
surface. The culture filtrate (metabolism solution) became pale 
yellow as growth proceeded, and after four weeks' growth was usually 
a pale yellow-orange.
The submerged cultures grew in small spheres which increased in 
size and number with time. A reasonable density of these spheres 
was achieved after three days and the culture then grew steadily until 
at about 9 days the mycelial pellets started to fall apart. This 
disintegration continued during the tenth and eleventh days, by which 
N time the mycelium appeared as short shreds.
(c) Flasks from flasks
To achieve even more uniform growth, the technique of inoculating 
from a 'seed' flask was later adopted. This involved inoculating 
several flasks (carrot medium) from slopes and growing shake 
cultures for a period of 4 days, by which time the culture was well 
established. The cultures were then combined, under sterile conditions, 
and 5 ml aliquots were transferred by means of a broken-ended sterile 
pipette to fresh flasks of the C.D.:carrot or C.D. medium which were 
then incubated at 24°C in the dark as before (i.e. surface culture).
Two millilitres of the growing culture were pipetted into the flask for 
the submerged culture. These flasks showed great uniformity of mycelial
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weight and were considered to be biosynthetically equivalent.
When the mycelial pellets were too large to pipette directly, 
the bulked cultures were first macerated, using a sterilised Atomix 
mixer, for a few seconds and then pipetted. Maceration had no 
adverse affect on the subsequent growth of the submerged cultures.
3.3.3 Course of fermentation of Altemaria altemata
Batches of thirty-three 250 ml Erlenmeyer flasks, plugged with 
cotton wool, were prepared, each containing 60 ml of C.D.:carrot 
medium. After sterilization, each flask was inoculated with spore 
suspensions obtained from a freshly grown carrot ’seed' flask of the 
chosen strain of A. altemata, either Nos. T149, T159 or T139, and 
incubated on a rotary shaker ( 240 rpm ) at 24°C. - The cultures 
were harvested at different times of growth by filtering through a 
Buchner funnel using a Whatman No. 1 filter paper and pressed dry.
Filtration took a long time, due to the slimy nature of the mycelium.
After harvesting, the following experiments were carried out on
mycelia and metabolism solutions. (Results in Table 3.4, Figs. 3.1 and 3.2).
The same procedure was applied to batches of twenty 1 litre 
conical flasks, containing 350 ml of C.D.-.carrot medium.
(a) Extraction of the metabolism solution (culture filtrate)
The culture filtrate was acidified to pH 2.0 and twice extracted 
with an equal volume of diethyl ether (or chlorbform) in a separating 
funnel. The combined ether layers were run into a weighed flask, 
evaporated to dryness and weighed. Before extraction, a sample
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(ca. 0.5 ml) of the culture filtrate was taken and subjected to the 
ferric chloride test to ascertain the presence of phenolic substances.
(b) Extraction of the mycelium
The pressed-dry mycelium was extracted by refluxing with acetone 
for 10 minutes. The extract was filtered into a weighed flask, the 
solvent removed on a rotatory evaporator, and the residue weighed.
Another method of extraction was the maceration of pressed-dry 
mycelium in an Atomix blender with acetone for 2-5 minutes, followed by 
filtration of the finely divided mycelium from the acetone. The mycelium 
was twice extracted with acetone in this way. As Sime reported, 129 
simply rinsing the flask containing the dried acetone extract with 
cold petroleum ether (b.p. 40-60°) achieved complete separation of 
the lipids from the remainder of the acetone extract.
(c) pH measurements
The pH of the metabolism solution was determined using an EIL 
pH meter, against standard buffers of pH 4.0, 7.0 and 9.0 at 20°C.
(d) Mycelium weight
The mycelium was pressed dry on a Buchner or Hirsch funnel 
attached to a water pump and then dried in an oven at 110°C for 
three hours. The dry mycelial weight was recorded.
(e) Glucose assay
Determination of the glucose concentration of the various
culture filtrates was carried out by polarimetry and with glucose 
oxidase.
The method used was a modification of that described by Weiner
i An
and Wirlinger (1970). 0.5 ml samples of the clear metabolism
solution (diluted 4-fold, 10-fold and 20-fold) and a sample of the 
original medium (diluted 100-fold) were transferred to test tubes to 
which 5 ml of enzyme-chromophore solution (glucose oxidase lOil/ml 
peroxidase 0.8 U/ml, and a colour reagent in phosphate buffer 100mM/1 
pH 7.0, obtained from Boehringer) was added to the tubes, and the 
solutions mixed. The tubes were incubated at 37°C for 30 (15) 
minutes. Two millimetres of 25% (v/v) sulphuric acid was then added 
to the tubes and the optical density was measured at 420 nm using a 
Unican SP 500 spectrophotometer. A blank (0.5 ml water) and a range 
of standard glucose solutions covering the range of 0-50 yg in 0.5 ml 
were measured using the same procedure. A standard curve for the 
determination of glucose was used.
In the early part of the project glucose concentrations were 
measured polarimetrically. However, this method suffered from the 
disadvantage that when the culture filtrates were coloured, the 
absorption of the 580 nm light made accurate readings of the optical 
rotations difficult.
(f) Chromatography of extracts
Both the acetone and ether extracts (or chloroform extracts) 
were dissolved in acetone and spotted onto a silica gel GF254 thin 
layer chromatography plate (20 cm x 10 cm or 20 cm x 20 cm, 0.25 mm 
thick), along with markers of altemariol. its methyl ether and
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other standard samples. The chromatogram was developed using the 
solvent system benzene:acetic acid (6:1, v/v). The plate was then 
removed from the chromatography tank and viewed under ultraviolet 
light.
3.3.4 Methods of separation of A. altemata metabolites
Altemariol and its mono methyl ether may be easily separated 
by means of their differing solubility in ethanol.
Few analytical methods have been reported for the Altemaria 
161—16 2metabolites. The most general method of analysis of mycotoxins
I (L O
is based on thin-layer chromatography (tic).
Thin layer chromatography was carried out on pre-coated silica 
gel (GF2 5 4) thin layer plates (0.25 and 0.50 mn).
To increase the tic resolution different solvent systems were tried. 
Altemariol, altemariol mono, di and tri-methyl ether, altenuene, 
altenusin and dehydroaltenusin were all chromatographed on tic plates 
in benzene/glc acetic acid, benzene/ethanol, chloroform/methanol, 
petroleum ether/benzene/CCJU /pyridine and chloroform/acetic acid/ 
ether. Of several solvent systems tried, benzene/acetic acid (6:1 
and 7:2 v/v), benzene/ethanol (95:5 v/v) and chloroform/methanol 
(95:5 v/v) were found to be the most satisfactory.
In addition to the detection under u.v. light at two wave 
lengths (254 and 350 nm) where altemariol and its mono, di and tri­
methyl ether give a violet fluorescence and altenuene a light green- 
yellow one. The plates were sprayed with a solution of 1% vanillin 
in concentrated H2S0it and then heated for 10 minutes at 110°C.
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Altemariol and its methyl ether gave a violet colour, altenusin 
yellowish-brown, and altenuene a yellowish-green colour. The spots 
were also made visible with iodine vapour (brown), and sulfanilic 
acid spray served as a good detecting reagent. Altenuene appeared 
as a yellow spot, altemariol as a cherry-red one, and altemariol 
methyl ether as a wine-coloured one.
The minimal detection by u.v. fluorescence was found to be 0.1 yg. 
Thus thin layer chromatography for rapid qualitative and quantitative
1 f i  1analysis of these compounds is very useful as reported by Pero.
For quantitative purposes the preparative chromatography method 
on silica gel thin-layer plates (0.5 to 1.0 mm) gave satisfactory 
results, by elution of the bands with hot ethanol.
Column chromatography was not as efficient as thin-layer 
chromatography for separation of Altemaria metabolites.
3.3.5 Preparation of isotope solutions
The isotopically labelled substances were obtained from the 
Radiochemical Centre, Amersham, and were in the form of freeze-dried 
solid material in evacuated vials. These vials were broken under 
sterile conditions and the labelled material carefully dissolved in
the volume of sterile distilled water needed to give a solution of
/
the desired activity levels (in a volumetric flask) and stored in a 
refrigerator at 4°C.
3.3.6 Radioassay procedure
An accurately weighed sample of the labelled compound was
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dissolved in dioxan (1 ml) and NE-250 liquid scintillator (5 ml) was 
added. This was counted in a liquid scintillation counter, Beckman 
LS100. The efficiency of counting was determined from the external 
standard ratio.
3.3.6.1 The assay of radioactive metabolites
The samples of metabolites (altemariol, its methyl ether, 
dehydroaltenusin, etc.) assayed were from the mycelial or metabolism 
solution extracts of A. altemata which were chromatographed on silica 
gel preparative thin layer plates. The bands corresponding to the 
compounds were eluted with methanol, the solvent was evaporated off 
under a stream of nitrogen. The weighed, dried extract was dissolved 
in dioxan or ethanol, and made up to the required volume (usually 5 ml) 
and was then ready for assay.
The concentration of alternariol was estimated by its absorption 
at 300 nm which was measured on u.v. spectrophotometers, (either Dnican 
SP 800 or SP 1800. Fig. 3.26 shows the plots of the optical 
density of altemariol solutions in dioxan at different wavelengths 
against altemariol concentrations.
Duplicate 1 ml samples of the ethanol or dioxan solutions of 
the above mentioned metabolites were pipetted into clean scintillation 
vials and NE250 liquid scintillant solvent (5 ml) was added. The vials 
were then capped and placed in the scintillation counter.
From the concentration measurement (or an accurate weight) and 
the activity measurements the specific activity of the sample could 
be calculated.
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FIG. 5.26 Plot of optical density against concentration 
of altemariol in solution in ethanol
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3.3.7 Autoradiographic methods
A convenient and inexpensive method based on the autoradiographic 
examination of extracts of plants, animals and microorganisms, grown 
in the presence of selected radioactively-labelled primary precursors 
was used in the present work.
This method has many advantages, for example the knowledge of 
their primary precursors automatically places the resulting meta­
bolites in a particular biosynthetic class, which thus provides 
potentially useful structural information. In addition, this approach 
is also likely to be of considerable taxonomic value. Furthermore, 
this system permitted the simultaneous investigation of a number of 
intermediates under uniform conditions by using mycelium from a single 
culture flask.
The simplicity and small scale of operation of the experimental 
system ideally lends itself to adaptation as a comparatively 
inexpensive general screening procedure. Thus, satisfactory auto­
radiograms are readily obtained using less than one gram (wet weight)
v
of freshly grown microbial cells shaken overnight in 2 ml or less of H2O or 
buffer (pH 7.5-8.0) containing low levels (e.g. 5-10 yCi.) of 1 Re­
labelled primary precursors, such as acetate and formate. This was 
followed by t.I.e. of metabolic extracts. The resulting 
chromatograms were placed in contact with Kodak X-ray film (cat. no.
305 6207) in the dark. This was then developed in the usual manner 
after a suitable exposure period, depending on the level of activity 
which was incorporated into the various metabolites.
This technique selectively detects metabolites of individual 
precursors and is used for a range of microbial products, including
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penicillin,1 2 5  a l t e m a r i o l  ^ 7 and the fungal 
phenalenones.
3.3.8 The incorporation of llfOacetate into A. altemata 
metabolites
Flasks containing carrot medium (60 ml in each 250 ml flask) 
were inoculated from sporing carrot agar slopes of A. altemata 
strains Nos. T19, T20, T21, T139, T149, T152, T153, T159 (cf. Table 3.1 P.98). 
After incubation for three days at 24°C on an incubator orbital shaker 
(240 r.p.m. ), these cultures were used as inoculi (seed flasks) for 
fresh flasks of the CD:carrot medium.
Each of the above strains was used to inoculate three flasks 
containing C.D. rcarrot medium (2.5%, v/v), making 24 flasks in all.
These were then incubated for seven days at 24-25°C on a shaker.
The resulting cultures were used as a course of mycelium for this 
study.
After seven days growth, the mycelia from each group of three 
related flasks were combined and filtered under vacuum. The mycelium 
was washed once with water and filtration was continued until all 
excess of moisture had been removed.: samples (1 g) of freshly
filtered mycelium were suspended in 2 ml portions of phosphate 
buffer (pH 7.8) contained in test tubes (1 in x 4 in).
The 14C-acetate precursor (5yCi) in sterile distilled water
was pipetted out and was dissolved in the buffer solution before the
addition of mycelium.
The tubes containing the buffered mycelial suspensions were
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incubated on the rotary shaker at 24°C for 24 hours, after which the 
mycelium was separated by filtration under vacuum. Each filtered 
mycelium was then pressed dry and then extracted three times with 
acetone (15 ml) for 15 minutes by refluxing. The acetone extracts 
filtered from the mycelium were combined. The metabolism solution 
( related filtrate) was also extracted three times at pH = 2 
with chloroform (3x3 ml). The chloroform phases were separated 
and combined. The extracts were taken to dryness on a rotary 
evaporator. The solid in each case was dissolved in 0.5 ml ethanol 
and 30 yl spotted onto a thin layer silica plate (20 cm x 10 cm x 
0.25 mm thick). These plates were developed in the solvent 
benzene : gl. acetic acid =6:1 (v/v) for one hour. After separation 
of the solvent from the surface of the silica, the plate was placed 
in contact with a sheet of X-ray film in a light-proof box for one 
week, to produce an autoradiographic picture of the labelled products 
derived from ^C-labelled acetate by A. altemata. (Figs. 3.3 and 3.4, 
pages 107-103, and Figs. 3.5 and 3.6 pages 111-112).
This experimental procedure was repeated for mycelia from 
cultures of 4, 5, 8 and 9 days old..
The incubation of precursors of various activities with the 
buffered mycelial suspensions were carried out for times ranging from 
2 to 48 hours; 24 hours was found to be a suitable time to give a 
clear autoradiogram for a 4-7 days submerged culture with 5 yCi 
^C-activity of the precursor.
To 0.1 ml of each extract (from 0.5 ml solution) and a 
quantitative volume of metabolism solution before and after extraction 
in a scintillation counting vial (see Table 3.5 page 109), 5 ml of 
NE250 liquid scintillator solvent was added, and samples were
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counted in a liquid scintillation counter. The percentage of acetate 
incorporated into the mycelium and culture filtrate was then 
determined for each.
3.3.9 Incorporation of ll*C-formate into the Altemaria altemata 
metabolites
The same procedure as in the previous experiment was carried 
out with 5 pCi of ll*C-formate instead of 1 ‘C-acetate. The incorporation 
of formate into metabolites of A. altemata and the differential 
uptake of these two primary precursors (acetate and formate) by 
the mould are discussed in this chapter (cf. Fig. 3.8 page 114 and 
Fig. 3.10 page 180).
3.3.10 Incorporation of ^C-acetate and 11*C-formate into 
Bptrytis allij metabolites
Ten submerged culture flasks containing C.D.:carrot medium 
(250 ml flask, 60 ml medium) were inoculated with a mycelium 
suspension obtained from seed flasks of either A. altemata strain 
No. T149 or B. allii strain No. T162. The resulting cultures, after 
\ seven days growth, were combined (related cultures) and used as a source 
of mycelium for autoradiographic studies. To obtain an autoradiogram of 
the labelled products derived from acetate and formate, the same procedure 
as in the previous experiment was carried out,.(cf. Fig. 3.14 page 128).
3.3.11 Effect of potential precursors and inhibitors on 
mycelial weight
A large number of flasks containing C.D.:carrot medium were 
prepared, and various weights of a number of substances were weighed
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into them. They were then resterilised by autoclaving at 15 psi for 
15 minutes, and , when cool, inoculated with A. alternata strains 
T139, T149 and T159 from the seed flasks (2.5$, v/v inoculum) and 
grown for 7 days. Mycelium was then filtered and dried in the oven 
vacuum and weighed. In some cases, the experiment was repeated for 
P. cyclopin, P. herquei and B. allii (cf. Fig. 3.13 page 127).
The substances added were altemariol, altemariol mono-, di- 
and tri-methyl ether, brominated derivatives (Fig. 3.12 page 123) 
and the ring open form of altemariol and its methyl ethers (Table 3.7a 
page 131), orsellinic acid and dibromo ethyl orsellinate (Fig. 3.11 
page 120 Table 3.6 _page 122). The derivatives of altemariol were 
prepared and are described in Chapter 2. The orsellinic acid sample 
was supplied by Professor R. Thomas and the dibromo orsellinic acid 
by Mr. J. Lari.
The brominated products were dissolved in the minimum of dioxan, 
altemariol and its methyl ether in 0.5 ml of ethanol or one drop 
DMSO. The lactonic acid fom in 0.1-0.3 ml 0.1-M NaOH and each of 
the rest in the 0 . 2 ml ethanol were usually added to the growing 
culture on the second day of growth. This method was followed to 
ensure normal growth at the time of inoculation.
3.3.12 Effect of altemariol and its derivatives on the
incorporation of ^C-labelled acetate into A. alternata 
metabolites
The shaken flasks containing C.D.:carrot medium (250 ml flask;
60 ml medium) were inoculated with A. altemata strains T139 and T149 
from the seed flasks (5$ v/v inoculum) and grown on a rotary shaker
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at 24° for 6 or 7 days. The mycelia were filtered through a Buchner
funnel, pressed dry and 1 g of freshly-grown mycelium of each sample
was weighed out and suspended in the 2 ml portions of phosphate buffer (or H20),
pH 8 , contained in test tubes (1 in). Precursor either 1 C^-acetate or
formate (5 yCi) and the substances such as altemariol (1), its mono-
and di-methyl ethers and in ethanol (or one drop EMSO) and the ring-
opened foirn (1) and its methyl ethers in 0.1 M NaOH, were dissolved in
the buffer solution before the addition of mycelium.
The tubes containing the buffered mycelial suspensions were 
incubated on the rotary shaker at 24°C for 24 hours, after which the 
mycelium was separated by filtration. Then mycelium and filtrate 
extracted with acetone and CHC13 respectively and examined chromato- 
graphically following autoradiographic examination, (cf. Figs. 3.15 
page 135 and 3.16 page 181).
3.3.13 Selection of a high yielding dehydroaltenusin culture
Samples (1.0 g) of freshly filtered mycelium were taken from 
each of the previously grown submerged cultures representing different 
strains of A. altemata (T19, T20, T21, T139, T149, T152, T153 and 
T159). When these were from 4 to 10 days old they were suspended in 
2 ml portions of phosphate buffer, pH 7.6, containing 5 yCi 1 ^ -acetate 
and 11+C-formate. These were then incubated in the rotary shaker (40 
rpm) at 24°C for 24 hours, after which time the mycelium was separated 
by filtration under vacuum and the filtrate examined chromatographically, 
followed by autoradiographic examination as previously described.
In this initial batch of eight cultures, strain T139 appeared to 
give a higher yield of dehydroaltenusin. Strain T139 on the submerged 
culture produced similar detectable products as the surface culture,
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but in smaller amounts, whereas the submerged culture of strain T149 
did not produce dehydroaltenusin, although a considerable.quantity of 
it was isolated from the surface culture. Hence strains 
T139 and T149 of A. altemata were chosen for these studies.
3.3.14 Preparation of radioactive altemariol monomethyl ether
Altemariol (40 mg) in dry acetone (15 ml) was refluxed with 
freshly distilled methyl iodide (0.0024 ml) containing ^GHal in 
10 ml dry acetone (with activity 25 pCi) in the presence of anhydrous 
K2CO3 (160 mg) for one hour. The reaction mixture was treated in the 
same way as for the methylation method for altemariol (already 
described in Chapter 2), with a yield of 67.9 mg. During its 
purification by preparative thin layer chromatography on a 0.25 cm 
thickness silica gel CF254 plate using a benzene: gl acetic acid 
system, the plate was exposed for two hours with an X-ray film, 
and after development the autoradiogram showed a variety of 
methylated products. The band corresponding to the altemariol 
methyl ether was eluted from the silica gel, then refluxed in 
ethanol (10 ml), filtered hot through a Hirsch funnel and the residue 
washed by re fluxing in ethanol several times (5 x 5 ml ethanol). The 
volume of the solution was reduced to about 3 ml, the flask stoppered 
and stored at 4°C. The fine, needle-like crystals which appeared 
from ethanol were filtered, washed with cold ethanol and dried (yield 
25.2 mg). The chromatographically homogenous product was observed to 
have an activity (14.99 pci) corresponding to the incorporation of 
59.61 of added ^CHsI into the altemariol monomethyl ether.
The results are tabulated below.
Sample
No.
. Sample weight 
(1 mg)
Sample activity 
dpm x 1 01*
Activity 
dpm/mg x 1 0H
1 0 . 2 26 132.0
2 0.3 40 132.1
3 0.4 53 132.2
Mean 132.1
The radioactive lt+C count is accurate to about 0.3%. The 
specific activity of the standard sample is thus 132 x 101* ±
3960 dpm/mg (163.2 ±0.5 yCi/m.mole).
The band corresponding to altemariol dimethyl ether on the 
plate was separated by elution of the silica gel with methanol.
Its xotal activity was found to be 4.579 yCi.
To check the stability of radioactive altemariol methyl ether 
during development of the silica gel plate in the benzene-acetic 
acid solvent system, a sample of the compound was dissolved in the 
ethanol, then applied to a silica plate and the chromatogram was 
developed in two dimensions(one direction at right angles to the 
other). No additional spots were observed.
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3.3.15 Other metabolites of A. altemata used as standards
Chromatographically homogeneous authentic samples of altenusin, 
dehydroaltenusin and altenuine were provided by Professor R Thomas.
3.3.16 Incorporation of radioactive altemariol monomethyl 
ether (2) into dehydroaltenusin-and related metabolites
The technique of autoradiographic examination was applied to 
follow the incorporation of altemariol monomethyl ether (2) into 
dehydro alt enusine and other compounds by A. altemata.
(a) Feeding of (2) to the growing surface culture of T149
Samples (lg) of freshly filtered mycelium from a surface culture 
of T149, at the age of 23 days, were suspended in 2 ml buffer, pH 7.8, 
contained in test tubes (1 in diameter). Radioactive altemariol 
methyl ether (4 mg, specific activity 163.2 pCi/m.mole) in one drop 
of DMSO was dissolved in the buffer solution before the addition of 
mycelium.
The tubes containing the buffered mycelial suspension were 
incubated on a rotary orbital shaker at 24°C for 24 hours, after which 
time the mycelium was separated by filtration. Both mycelium and 
filtrate were extracted and quantitatively (0.02 ml from 0.5 ml) 
chromatographed on a silica plate (0.25 mm. thickness) in benzyne- 
acetic acid;glacial (6:1, v/v). The plate was exposed with X-ray 
film and developed after three days’ exposure time. Two culture 
controls were prepared from the same mycelium source, incubated with 
2.5 pCi of ll*C-labelled acetate or formate, and then treated in the 
same way as the culture to which (2) was added (Fig. 3.18 and Table 
3.8 pages 138-139).
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(b) Feeding of (2) to the growing submerged cultures of T139 and T149
The radioactive compound (2) (2.5 mg 1.488 yCi specific activity 
163 yCi/m.mole) in one drop DiMSO was fed to the 7-8 days old 
resuspended mycelium of T149 (submerged culture and two other control 
samples containing 2 yCi 14Oacetate and 2 yCi ll|C-formate were treated 
as previously described (Fig. 3.19 page 141). The same conditions were 
applied to the feeding of this compound to the submerged culture of 
strain T149. The radioactive lactonic free acid form of (2) in 0.1 ml 
1 M-NaOH was dissolved in the buffer solution before addition of 
mycelium and then treated in the same way as the previous cultures 
(Fig. 3.20 page 143).
The spots corresponding to the radioactive metabolites were 
scraped off the plate and eluted into scintillation counting vials 
with diethyl ether. The ether, and the traces of the chromatographic 
solvent, were evaporated under a stream of nitrogen, NE250 (ml) added 
and the samples counted in the scintillation counter (Table 3.10 page 142).
The experiment was repeated and the isolated metabolites were 
examined by studying their chemical and physical properties.
Examination of the isolated of radioactive dehydroaltenusin and 
altenusin was carried out as described in the following section.
3.3.17 Oxidation of altenusin to dehydroaltenusin with
*i r r
ferric chloride
Altenusin (10 mg) was dissolved in the minimum volume of ethanol 
and an equal volume of water was added. Aqueous FeC£ 3 was added 
dropwise with shaking until the evanescent violet colour was no 
longer produced, and a slight permanent brown colour could be seen.
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As more ferric chloride was added, a yellow precipitate was fonned 
(8.5 mg). This was identical in its chemical and physical 
properties to dehydroaltenusin.
1653.3.18 Reduction of dehydroaltenusin to altenusin
Dehydroaltenusin was dissolved in a small amount of ethanol and 
heated. Saturated aqueous sodium hydrosulphite was added to the 
yellow solution, and the colour was immediately discharged. The 
mixture was cooled, acidified and extracted with ether. The ether 
was evaporated to dryness and the residue recrystallized from CHC£3. 
Colourless crystals were obtained which were identified as altenusin.
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FIG. 5. 10 Comparative autoradiogram showing (x^ C)-acetate and (1I+C) formate- 
derived mycelial constituents of A. altemata strains T139,
T149 and T152.
Conditions as in Fig. 3.3 using 7 days culture.
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FIG. 5.16 Autoradiogram showing inhibitory effect of the lactonic acid
form of altemariol di and trimethyl ethers (24 and 2S_
respectively) on the metabolism of A. altemata T139.
Mycelium grown on C.D: carrot (7 days at 24°) resuspended
in buffer (1 g./2 ml.) containing feeding components (2 mg.)
andf1 Vd-acetate (2yCi), then incubated 24 hours prior to
extraction of resulting mycelium. 1 - plus 11+C-acetate (control)
2 and 3 - plus (24)
4 - plus (25)
5 - plus altemariol (22)
(lactonic acid)
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FIG. 3.17 Autoradiogram showing (ll+C) formate-derived metabolism 
solution constituents of A. altemata strain 1139. 
Conditions as in Fig. 3.3 following incubation of
(ll4C) formate (2 yCi/2 ml.) with resuspended mycelium 
of different age.
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